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ABSTRACT

Survival of Mycoplasma Species in Recycled Bedding Sand and Possible Implications for
Disease Transmission to Ruminants
by

Anne E. Justice-Allen, Master of Science
Utah State University, 2010

Major Professor: Dr. David Wilson
Department: Animal, Dairy and Veterinary Sciences
Mycoplasmas are a group of bacteria which are small in size, lack a cell wall, and
have small genomes in comparison to other bacteria. The members of the group that are
pathogenic utilize several mechanisms to evade the host’s immune system. These
processes affect surveillance and control mechanisms such as serologic testing and
vaccination. Many of these organisms cause diseases of livestock, which heavily impact
production parameters such as weight gain, milk yield, and egg production.
Mycoplasmas also cause disease in people.
Mycoplasma spp. can cause mastitis, metritis, pneumonia, and arthritis. The
currently documented routes of transmission of Mycoplasma spp. are through fomites and
by direct animal contact. The existence of environmental sources for Mycoplasma spp.
and their role in transmission are poorly characterized. Mycoplasma spp. (confirmed as
M. bovis using PCR) was found in recycled bedding sand from a dairy experiencing an
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outbreak of mycoplasma mastitis. The possibility of a persistent environmental source of
Mycoplasma spp. in recycled bedding sand was further investigated using recycled sand
from the dairy. Study objectives included determining factors associated with the
persistence of Mycoplasma spp. in recycled bedding sand and the duration of survival of
mycoplasmas in the sand. We also evaluated 2 disinfectants at 2 different concentrations
each for the elimination of Mycoplasma spp. from contaminated sand.
Mycoplasma spp. survived in the sand pile intermittently over a period of 8
months. The concentration of Mycoplasma spp. within the sand pile was directly related
to temperature and precipitation. The survival of Mycoplasma spp. at a greater than
expected range of temperatures suggests the formation of a biofilm. Ideal temperatures
for replication of Mycoplasma spp. occurred between 15 °C and 20 °C. Moisture in the
sand and movement of the sand pile also appeared to play a role in replication of
mycoplasmas. Sodium hypochlorite (0.5%) and chlorhexidine (2%) were efficacious in
eliminating Mycoplasma spp. from contaminated bedding sand. Recycled bedding sand
could be an environmental source of Mycoplasma spp. infections, including M. bovis, in
dairy cows. Future studies should investigate the contribution of this environmental
source to the epidemiology of mycoplasma infections in dairy cattle and other ruminants.
(124 pages)
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CHAPTER 1
INTRODUCTION

Disease is a state where normal physiological processes are disrupted in a part,
organ, or system of an organism resulting in signs or symptoms. Disease can be caused
by many different mechanisms and agents, such as infection, genetic defect or
environmental stress. Bacteria can be both disease agents as well as participants in a
host’s normal physiological processes. Microbiologists and epidemiologists have
become increasingly aware that just as with macroorganisms, microorganisms fit into
ecological niches both within and outside of the host. One current model describes
disease as an interaction between the host, the environment, and the agent.
This thesis describes the characteristics of one set of organisms, the mycoplasmas,
and the mechanisms by which a number of them cause disease in man and animals.
Characteristics of mycoplasmas that are important to consider in the investigation and
management of disease outbreaks are the requirements for growth and laboratory
isolation, the routes of transmission between animals, the methods available for
identification of infected animals, and the value of vaccines, antibiotics, or management
and husbandry practices for control. The diseases caused by mycoplasmas are both acute
and chronic, and many are important because of the impact of the infections on the
productivity of livestock animals and birds.
Because this group of organisms lacks a cell wall, environmental survival has
been considered to be short and the primary routes of transmission have been described
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as by direct contact between animals or by contaminated wet surfaces such as milking
equipment (Jasper, 1977; Nagatomo et al., 2001; González and Wilson, 2003). During an
investigation into an outbreak of mastitis, Mycoplasma bovis was isolated from the
infected dairy cows and from the sand which was used to bed their freestall housing.
Evaluation of the bedding materials at several other mycoplasma-positive dairy farms
found 2 additional farms also had M. bovis in the bedding. This finding led to the
development of the observational study of the survival of a mycoplasma species,
confirmed as M. bovis by PCR, described in this thesis. The results of this research could
affect how mycoplasmal diseases, specifically mycoplasmal mastitis, are managed.
REFERENCES

González, R. N., and D. J. Wilson. 2003. Mycoplasmal mastitis in dairy herds. Vet.
Clin. North Am. Food Anim. Prac. 19:199-221.
Jasper, D. E. 1977. Mycoplasma and mycoplasma mastitis. J. Am. Vet. Med. Assoc.
170:1167-72.
Nagatomo, H., Y. Takegahara, T. Sonoda, A. Yamaguchi, R. Uemura, S. Hagiwara, and
M. Sueyoshi. 2001. Comparative studies of the persistence of animal mycoplasma under
different environmental conditions. Vet. Microbiol. 82:223-232.
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CHAPTER 2
LITERATURE REVIEW OF MYCOPLASMAS—PHYLOGENY, GROWTH
REQUIREMENTS, DISEASES, AND PATHOGENESIS
History and Phylogeny
The term mycoplasma has been used to designate both members of a class of
organisms Mollicutes as well as members of the genus Mycoplasma (Razin, 1978). In this
thesis, the term mycoplasma will refer only to those members of the genus. The Mollicutes
have been grouped together because of the common characteristics of a small genome
(0.58 - 2.2 Mbp) with low guanine-cytosine content (a measure of DNA variability used to
characterize prokaryotes) and an absent cell wall (Razin and Hermann, 2002). The first
mycoplasma organism was identified in 1896 by Nocard and Roux as the agent of bovine
pleuropneumonia (Nocard et al., 1896). Originally the organism was classified as a virus
because it was filterable (passed through a Chamberland filter), could not be cultured using
the solid agar media available, and could just be detected with the light microscopes in use
at the time (Nocard et al., 1896; Eaton et al., 1945; Goodburn and Marmion, 1962; Harwick
et al., 1972). Because the organism was not readily visible, Koch’s postulates were not
technically satisfied but the researchers were able to remove the organism from infected
calves, grow it in semi-permeable, membranous pouches in the peritoneal cavities of
rabbits, (without the rabbits becoming infected), inoculate a naïve calf with the culture, and
cause the classic form of the disease (Nocard et al., 1896). The second mycoplasma to be
identified and isolated by inoculation of chick embryos with filtered (600 mµ collodion
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membrane) sputum from human patients was M. pneumoniae (Eaton et al., 1945; Goodburn
and Marmion, 1962; Harwick et al., 1972). There are now approximately 200 validly
described species in 8 genera (Table 2.1, Johansson and Peterson, 2002; International
Committee on Systematics of Prokaryotics, 2003). These organisms occur in insects,
plants, plant surfaces, animals, bovine and ovine rumens, and people. The Mollicutes have
been placed in the phylum Firmicutes with the classes Bacilli and Clostridia based on
rRNA sequence analysis (Maniloff, 2002). This also reflects their evolutionary origin in
the Late Proterozoic when the AAP (Acholeplasmataceae, Anaeroplasmataceae, and
Table 2.1: Classification of Mollicutes (adapted from Razin and International Committee
on Systematics of Prokaryotics)
Order

Mycoplasmatales

Family

Genus

No. of
species1

Mycoplasma

111(5)

Ureaplasma

7

Entomoplasma

6

Mesoplasma

12

Spiroplasma

452

Acholeplasma

14

Phytoplasma3

(8)

Anaeroplasma
Asteroplasma

4
1

Mycoplasmataceae

Entomoplasmataceae
Entomoplasmatales
Spiroplasmataceae

Acholeplasmatales

Anaeroplasmatales
1

Acholeplasmataceae

Anaeroplasmataceae

Candidate species in parentheses; from ICSP
Includes 11 unnamed species
3
Razin tentative classification; not in ICSP
2

Habitat
man,
animals
man,
animals
insects,
plants
insects,
plants
insects,
plants
animals,
plant
surfaces
insects,
plants
rumen
rumen
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Phytoplasma) branch diverged from the Streptococcus branch (Maniloff, 2002). This
divergence coincided with genome reduction and loss of the ability to produce a cell wall
(Maniloff, 2002). Two more divergences occurred in the Middle Ordovician and at the
Silurian-Devonian boundary which resulted in the separation of the Mycoplasmataceae
branch containing the genera Mycoplasma and Ureaplasma (Maniloff, 2002).
Mycoplasmas evolved dramatically with the appearance of mammals and other vertebrates
approximately 191 million years ago (Maniloff, 2002).
With the advent of DNA sequencing methods, microorganisms are being
reclassified based on similarities in the nucleotide sequence of all or part of the genome.
Recently, 2 groups of previously identified red blood cell (RBC) parasites, formerly called
Eperythrozoon spp. and Haemobartonella spp., have been moved from the Rickettsiales to
Mycoplasmatales class Mollicutes. Most microbiologists agree with this change because
the similarity between the sequences of 2 gene segments, the 16s rRNA and the RNase P
gene, of the former Eperythrozoon spp. and Haemobartonella spp. and M. pneumoniae is
76% (Neimark et al., 2001; Tasker et al., 2003; Uilenberg et al., 2004). Additional
similarities between the hemoparasites and mycoplasmas are the absence of a cell wall,
small size (0.3 to 0.5 µm), pleomorphic morphology, and the presence of attachment
structures (Neimark et al., 2001). Some microbiologists believe that the organisms should
be placed in the Mycoplasma genus (Niemark et al., 2001). Others indicate that because
the reclassified group attaches only to RBC (some appear free in the plasma), and the
similarity is less than the similarity that occurs between other closely related genera, such a
reclassification is inappropriate (Uilenberg et al., 2004).
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Physiology and Growth Requirements
As a group, the mycoplasmas have lost, through genome reduction, many
synthetic and physiological biochemical pathways. Acholeplasma laidlawii, M. hominis,
and M. mycoides ssp. mycoides lack the ability to synthesize de novo purine and
pyrimidine bases (Razin, 1978). In contrast, M. mycoides ssp. mycoides does have the
capacity to synthesize all of the nucleotides, including adenosine triphosphate and
cytosine triphosphate from the nucleosides guanine, uracil, and thymine (Razin, 1978).
Analysis of the genomes for M. genitalium, M. pneumoniae, and U. urealyticum found no
genes coding for amino acid metabolism and a small number of genes for lipid
metabolism and energy metabolism when compared to bacteria such as Escherichia coli
and Bacillus subtilis (Pollack, 2002). There are 3 pathways utilized by mycoplasmas for
energy production: fermentation of sugars to lactate, oxidation of lactate or pyruvate, and
the metabolism of L-arginine to ornithine (Keçeli and Miles, 2002). There is significant
variation among the mycoplasma species, with some having the mechanisms for all 3
metabolic pathways and some having only 1 route of energy generation. The EmbdenMeyerhoff-Parnas pathway is present to some degree in all of the Mollicutes studied to
date and is believed to be the primary method of ATP generation for the group (Pollack et
al., 1997). Ureaplasma is unique in the group because of its ability to hydrolyze urea
(Razin, 1978). All of the various physiological pathways have not been identified for all
mycoplasma species. The number of genes for transcription and translation are
comparable to those of other bacteria (Pollack, 2002).
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The result of the reduction in the physiologic capacities of mycoplasmas is the
requirement for complex media when attempting to isolate or culture the organisms. The
first microbial cultures with formulated media were accomplished in the 1930’s by
Ledingham and Gey working separately using media enriched with serum or human
placental cord blood (Morton et al., 1952; Harwick et al., 1972). The identification by
Klieneberger in 1935 of classical mycoplasma colonies contaminating a culture of
Streptobacillus moniliformis as “L forms” led to years of confusion between bacterial
variants lacking cell walls and Mycoplasma spp. (Morton et al., 1952). The confusion
began to be resolved in 1961 when Liu demonstrated that the agent of atypical
pneumonia was particulate (Harwick et al., 1972). Shortly thereafter, the organism was
cultured on solid media and named Mycoplasma pneumoniae (Chanock et al., 1962). The
researchers determined that both horse serum and yeast extract were required for growth
of the organism. Since then many media have been developed for the isolation of
mycoplasmas from animal tissues and fluids (Table 2.2).
The most basic and earliest medium used for mycoplasma culture consists of 50 g
dehydrated beef heart, 10 g peptone, 5 g NaCl, and 14 g agar per liter of distilled water
(Morton et al., 1952; Hayflick and Chanock, 1965). By 1951, this product was available
commercially and a number of researchers were experimenting with additional
supplementation in order to increase the isolation of various Mycoplasma spp. (Morton et
al., 1952; Chanock et al., 1962; Barber and Fabricant, 1962; Hayflick and Chanock,
1965). One of the media developed by Chanock et al. (1962), Hayflick’s medium, is still
used, with the modification of the addition of various antibiotics, for the isolation of
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Table 2.2: Media used for isolation of mycoplasmas
Component

Hayflick’s

Friis’

L'Ecuyer’s

SP4

Broth

Difco PPLO1

PPLO and BHI2

PPLO

PPLO

Protein

pooled horse
serum

horse and pig
serum

pig serum,
gastric mucin,
lactalbumin

Sterol

yeast extract

yeast extract

yeast extract

Carbohydrate
Antibiotic
Other

digest of
casein, digest
of gelatin, fetal
bovine serum
yeast extract,
yeastolate3

DEAE4 dextran
bacitracin

polymyxin B,
penicllin,
amphotericin B,
thallium acetate
penicillin
CMRL 10665

1

PPLO = Pleuropneumonia-like organism media
BHI = Brain heart infusion
3
Yeastolate = the water soluble portion of autolyzed yeast
4
DEAE = diethylamino ethanol
5
CMRL 1066 = Connaught Medical Research Laboratories 1066, a defined medium
consisting of amino acids, nucleic acids, and vitamins. An example of 1 commercial type
is available from Sigma (http://www.sigmaaldrich.com/united-states.html).
2

Mycoplasma spp. (Table 2.2). Other media which are in common use are Friis’ and SP4
(Table 2.2). It has become common practice to modify these media with the addition of
various antibiotics such as thallium acetate, penicillin, ampicillin, polymyxin B, and
kanamycin (Barber and Fabricant, 1962; L’Ecuyer, 1969; Harwick et al., 1972; Ciprián et
al., 1988).
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Mycoplasmas and Disease in Animals and Man
The impetus for the development of media to isolate mycoplasma organisms was
the realization that there was a group of microorganisms causing serious diseases in
animals and man which was smaller than other bacteria and not a virus. Nocard et al.
were working to discover the agent of contagious bovine pleuropneumonia, a devastating
disease of cattle which still has a significant economic impact in southern and eastern
Africa (Thiaucourt et al., 2004). The first pathologic mycoplasma organism discovered
to cause disease in man, M. hominis, was isolated from a Bartholin’s gland abscess in
1937 (Morton et al., 1952; Harwick et al., 1972; Bébéar, 2002). This was followed by the
identification in 1944 of M. pneumoniae as the cause of Primary Atypical Pneumonia
(PAP) which was initially called Eaton’s agent and thought to be a virus (Eaton et al.,
1945; Harwick et al., 1972). By 1965, pathogenic mycoplasmas had been identified in 15
different animals (Hayflick and Chanock, 1965). Previously unrecognized species of
mycoplasma have been identified in the past 10 years in part due to the development of
molecular and DNA based methods such as PCR (Kirchhoff et al., 1997; Helmick et al.,
2002; Hammond et al., 2003; Haulena et al., 2006). Table 2.3 lists the currently
recognized important pathogenic mycoplasmas of animals and man as well as the clinical
syndromes caused by each. The pathogenesis, epidemiology, and treatment of some of
the more important mycoplasmal diseases of animals and man are reviewed.
Mycoplasma pneumoniae.
Of the 6 mycoplasmas associated with disease in man, M. pneumoniae is the
most thoroughly studied and the most important (Waites and Talkington, 2004; Vervolet
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et al., 2007). It was first cultured in 1944 but thought to be a virus because it was
filterable and was not susceptible to penicillin (Eaton et al., 1945). In1961, Goodburn
Table 2.3: Major pathogens of animals and man grouped by host species
Host
Human

Agent
M. pneumoniae

Human

M. hominis

Human
Cattle
Cattle/bison/deer
Cattle
Cattle
Cattle/bighorn sheep
Cattle/bison
Cattle

Goats/sheep
Sheep/deer
Sheep/bighorn sheep
Horses
Swine
Swine
Swine
Mice/rats
Mice/rats

U. urealyticum
M. mycoides ssp. mycoides
M. bovis
M. californicum
M. canadense
M. arginini
M. bovigenitalium
M. dispar
M. capricolum ssp.
capricolum
M. capricolum ssp.
capripneumoniae
M. agalactiae
M. conjunctivae
M. ovipneumoniae
M. felis
M. hyopneumoniae
M. hyorhinis
M. hyosynoviae
M. pulmonis
M. arthritidis

Turkeys/chickens

M. gallisepticum

Turkeys

M. meleagridis

Turkeys/chickens
Turkeys/chickens
Passerine birds
Tortoises
Crocodiles

M. iowae
M. synoviae
M. gallisepticum
M. agassizii
M. crocodyli

Goats
Goats

Disease
Primary atypical pneumonia
Salpingitis, pyelonephritis,
pelvic inflammatory disease
Urethritis
Pleuropneumonia
Mastitis
Mastitis
Mastitis
Mastitis
Infertility, mastitis
Calf pneumonia
Arthritis, mastitis,
pneumonia, septicemia
Pleuropneumonia
Mastitis
Keratoconjunctivitis
Pneumonia
Pleuritis
Pneumonia
Arthritis, pneumonia
Arthritis
Respiratory disease
Arthritis
Sinusitis, respiratory
disease
Air sacculitis, embryo
mortality
Embryo mortality, arthritis
Synovitis
Conjunctivitis
Sinusitis, conjunctivitis
Arthritis
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and Marmion observed the organism as a small coccobacillus on the mucous layer of
bronchial epithelium and found that it was susceptible to tetracycline and erythromycin
(Goodburn and Marmion, 1962). At about the same time, the organism was successfully
cultured on a solid medium (Chanock et al., 1962). At present, the entire genome has
been sequenced, the mechanisms of adhesion to the host cell have been elaborated, and
several modes of pathogenesis and immune system modulation have been described
(Waites and Talkington, 2004).
First described as the agent for PAP, M. pneumoniae causes a broad range of
clinical manifestations in humans. The usual incubation period ranges from 1 to 3 weeks
(Waites and Talkington, 2004; Vervolet et al., 2007). The earliest symptoms are nonspecific and consist of fever, sore throat, hoarseness, headache, chills, myalgia, and
earache (Waites and Talkington, 2004; Vervolet et al., 2007). A harsh, persistent, nonproductive cough is a classic sign but it is not pathognomonic (Waites and Talkington,
2004; Vervolet et al., 2007). Mycoplasma pneumoniae has been determined to be the
cause of 15% to 20% of the reported pneumonias (Waites and Talkington, 2004);
pneumonia occurs in 3% to10% of the cases that begin with milder symptoms (Vervolet
et al., 2007). Extra-pulmonary pathology occurs in 25% of infected patients (Waites and
Talkington, 2004). The organism has been cultured from joints, cerebrospinal fluid, and
the pericardium (Waites and Talkington, 2004). The most common extra-pulmonary
complications are dermatological and consist of maculopapular and vesicular rashes,
conjunctivitis, erythema multiforme, and ulcerative stomatitis (Waites and Talkington,
2004). Non-specific arthralgias, myalgias, and septic arthritis occur in 14% of patients
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(Waites and Talkington, 2004). Less common sequelae are encephalitis, meningitis,
polyradiculitis, pericarditis, myocarditis, hemolytic anemia, disseminated intravascular
coagulation, acute glomerulonephritis, otitis externa, and otitis media (Waites and
Talkington, 2004). Many of the extra-pulmonary disease syndromes have an
immunologic component which is a result of the interaction of M. pneumoniae with
immune cells and the production of various cytokines. This will be discussed further in
the section on mycoplasmas and the immune system.
Disease occurs most frequently in children from 5 to 15 years of age, and young
adults that are housed in group settings such as college dormitories, military barracks,
and prisons (Waites and Talkington, 2004; Vervolet et al., 2007). Several studies have
found that epidemics occur every 3 to 5 years (Jacobs, 2002; Waites and Talkington,
2004). Genetic research has determined that there are 8 subtypes of M. pneumoniae
divided into 2 major groups based on variations in the P1 adhesin gene (Jacobs, 2002;
Waites and Talkington, 2004). Epidemiologic studies have found that when an epidemic
occurs, the causative subtype isolated is different than the 1 that had caused the most
recent previous outbreak (Jacobs, 2002; Waites and Talkington, 2004). In 51% of cases,
M. pneumoniae occurs in a co-infection with viruses and other bacteria and there is
evidence that it intensifies the severity of viral infections (Waites and Talkington, 2004;
Vervolet et al., 2007).
Mycoplasma pneumoniae causes disease through several different mechanisms.
The first step in the process is binding to the host cell by means of several adhesin
proteins which appear to attach to host sialoglyco-conjugates and sulfated glycolipids

13
(Waites and Talkington, 2004; Vervolet et al., 2007). The organism produces hydrogen
peroxide hydroxy radicals, and superoxide anions which damage the ciliated cells of
respiratory epithelium (Waites and Talkington, 2004; Vervolet et al., 2007). Mycoplasma
pneumoniae also activates the complement system causing the production of tumor
necrosis factor α (TNF-α), interferon γ (IFN-γ), interleukin 1β (IL-1β), interleukin 6 (IL6), and interleukin 8 (IL-8), an immune response consisting of both type 1 and type 2
cytokines (Waites and Talkington, 2004; Vervolet et al., 2007). These factors can be
effective in eliminating the infection but can also exacerbate underlying chronic diseases
such as asthma, and chronic obstructive pulmonary disease (COPD; Waites and
Talkington, 2004; Vervolet et al., 2007). Pathologic changes consist of ulceration of
airway epithelium, edema of the bronchi and bronchioles, cellular (neutrophils,
lymphocytes, plasma cells, and macrophages) infiltrates of the bronchioles and alveoli,
Type II pneumocyte hyperplasia, pleural effusions and in more severe cases, lung
abscesses and pulmonary fibrosis (Waites and Talkington, 2004).
Due to fastidious culture requirements and the slow growth profile (21 days),
diagnosis of M. pneumoniae by culture is difficult. Definitive species identification of
positive cultures requires species specific anti-sera (Mahon et al., 2007). While there is
an enzyme-linked immunosorbent assay (ELISA) available, its limit of detection is very
near the typical number of organisms in a sputum sample which means that there are a
number of false negatives resulting in a low sensitivity for the test (Waites and
Talkington, 2004; Vervolet et al., 2007). Numerous PCR techniques have been
developed and used but results vary with the specific methods and primers used (Waites
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and Talkington, 2004). Polymerase chain reaction will likely become the diagnostic
method of choice when a method is perfected. At present, the diagnosis is usually made
with serologic methods. Complement fixation (CF), indirect immunofluorescent
antibody, particle agglutination, and ELISA have all been used (Waites and Talkington,
2004; Vervolet et al., 2007). Enzyme-linked immunosorbent assay and particle
agglutination detect IgM and IgG antibodies to M. pneumoniae (Waites and Talkington,
2004; Vervolet et al., 2007). The ELISA tests are the most widely used method for
diagnosing M. pneumoniae infection but like all serologic tests, they are limited by the
requirement for testing of acute and convalescent samples (Waites and Talkington, 2004;
Vervolet et al., 2007).
Mycoplasma pneumoniae infection usually responds to treatment with macrolides,
ketolides (a subset of macrolides), tetracyclines, and fluoroquinolones and treatment
failures have rarely been reported (Waites and Talkington, 2004; Vervolet et al., 2007).
Minimum Inhibitory Concentration (MIC) testing is generally considered unnecessary
because there is little variability for in vitro results and very few antibiotic resistant M.
pneumoniae organisms have been documented (Waites and Talkington, 2004).
Mycoplasma pneumoniae is also susceptible to chloramphenicol, aminoglycosides, and
streptogramins however these are seldom used due to the potential for side-effects
(Waites and Talkington, 2004). Erythromycin has been the antibiotic of choice especially
for children, however it is being supplanted by the newer macrolides such as
azithromycin and clarithromycin because they are tolerated better and have once or twice
a day dosing while erythromycin must be administered every 6 hours (Waites and
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Talkington, 2004; Vervolet et al., 2007). For adults, the newer fluoroquinolones are often
the preferred treatment because they are effective against a number of respiratory
pathogens (Waites and Talkington, 2004).
Mycoplasma mycoides ssp. mycoides
Contagious bovine pleuropneumonia (CBPP) is a highly contagious and
economically important disease of cattle caused by Mycoplasma mycoides ssp. mycoides
Small Colony (SC) and was first described by Gallo in 1564 (Thiaucourt et al., 2004). It
has occurred in every region of the world with cattle except Madagascar and South
America; however it has been eradicated from North America, most of Europe, and
Australia (Thiaucourt et al., 2004). It was the first mycoplasma for which Koch’s
postulates were satisfied and to be grown on artificial media (Nocard et al., 1896).
It causes disease in domestic cattle species (Bos taurus, B. indicus) and water
buffalo (B. bubalis; OIE, 2009a). The course of the infection may be peracute, acute,
subacute, or chronic. Acute signs consist of fever, purulent to mucopurulent nasal
charge, a soft moist cough, and occasionally epistaxis. As the disease progresses, the
animals become reluctant to move, and stand with outstretched necks. Calves may also
have septic arthritis. With subacute infections, the signs are basically the same but
milder. Animals that are chronically infected have recurrent low grade fevers, a loss of
body condition, and will exhibit respiratory signs with exertion (Thiaucourt et al., 2004).
Contagious bovine pleuropneumonia is transmitted by respiratory droplets from
infected animals. Respiratory secretions, urine, and uterine discharges can be infectious
(Thiaucourt et al., 2004). There is some evidence for transfer of disease through
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contaminated feed (Windsor and Masiga, 1977). The organism can survive in the
environment for 3 days in the tropics and 2 weeks in temperate climates (Thiaucourt et
al., 2004). The incubation period is usually between 3 and 6 weeks but can be as long as
6 months (Thiaucourt et al., 2004; OIE, 2009a). The long incubation period causes
outbreaks to intensify slowly. As the number of organisms in the environment and
infected animals increase, those animals that are still susceptible experience severe acute
and peracute disease (Thiaucourt et al., 2004). Antibiotic treatment is not recommended
either for the individual animal or as a means to control an epidemic because of poor
clinical response and cure rates (Thiaucourt et al., 2004).
As with M. pneumoniae in man, M. mycoides ssp. mycoides SC infection begins
with the organism adhering to the respiratory epithelium (Thiaucourt et al., 2004). The
signs of the disease are caused by severe bronchiolitis, bronchopneumonia, and fibrinous
pleuritis. Interlobular lung septa are widened with fluid or fibrous tissue (Kahn and Line,
2005). Microscopically, there is a severe fibrinous pneumonia, fibrinous pleurisy,
thrombosis, and areas of necrosis (Kahn and Line, 2005). Sequestra form when necrotic
tissue becomes encapsulated by a fibrous layer up to 1 cm thick (Thiaucourt et al., 2004).
On a molecular level, only a few of the cytotoxic compounds and processes have been
determined. Strains of M. mycoides ssp. mycoides SC that are more virulent produce
more hydrogen peroxide through a metabolic pathway that utilizes glycerol (Pilo et al.,
2007). A polysaccharide galactan, 6-O-β-D-galactofuranosyl-D-galactose, has also been
found to contribute to the virulence of the organism perhaps because it is similar to
galactans in the lungs of cattle (Thiacourt et al., 2004; Pilo et al., 2007). Much of the
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research into the effects of M. mycoides ssp. mycoides SC has been directed at production
of an effective vaccine rather than characterizing the cytokines produced during the
immune response (Dedieu et al., 2006; Totté et al., 2007). Infection with M. mycoides
ssp. mycoides SC is known to cause a marked inflammatory reaction and TNF-α is
thought to play a role (Thiacourt et al., 2004).
Definitive diagnosis of CBPP is easier now than when Nocard et al. were using
membranous pouches implanted in rabbits (Nocard et al., 1896; Thiacourt et al., 2004).
The organism can be cultured in 2 to 3 days from aseptically collected pleural fluid from
an animal not previously treated with antibiotics (Thiacourt et al., 2004). As with other
mycoplasmas, specific identification is accomplished with biochemical tests, growth
inhibition by hyperimmune serum, or PCR (Thiacourt et al., 2004). In addition, the
organism can be detected using an agar-gel precipitation test directed at galactan
(Thiacourt et al., 2004). A CF test and a competitive ELISA test have been recognized
by the World Animal Health Organization (OIE) as valid for serological diagnosis of
herds infected with CBPP (Thiacourt et al., 2004; Gonçalves et al., 2008; OIE, 2009a).
Neither test detects vaccine induced antibodies so they can be used to measure the
prevalence of naturally acquired infections (Thiacourt et al., 2004). However both have
sensitivities that are less than 80% which means that disease rates are underestimated and
low levels of disease will not be detected (Gonçalves et al., 2008). An immunoblot test
was developed in Portugal in1996 and a study comparing it to the OIE approved CF test
found that the CF test was also detecting M. bovis antibodies in addition to those against
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M. mycoides ssp. mycoides which resulted in an overestimation of prevalence (Gonçalves
et al., 2008).
The importance of CBPP to the local and national economies of the regions
affected by it has directed the methods used to control or eliminate it. In most
circumstances, emphasis is placed on eliminating it from or controlling it in a herd as
opposed to treating the individual animal. Control methods consist of culling affected
herds, vaccination, restriction of animal movement, and quarantine. Serologic testing is
used in regions that border endemic areas. Importation of animals from positive
countries into those free of CBPP is also prohibited (Thiacourt et al., 2004).
Mycoides Cluster Species of Sheep and Goats
Four species of mycoplasmas in the mycoides group cause disease in sheep and
goats. Because these organisms are closely related genetically and immunogenically, it
has been difficult until recently to clearly identify the organism causing each syndrome
and accurately describe the diseases (Lefèvre and Thiacourt, 2004). Three organisms in
the mycoides cluster, M. mycoides ssp. mycoides LC (large colony), M. mycoides ssp.
capri, and M. capricolum ssp. capricolum and 2 other mycoplasmas, M. putrefascens and
M. agalactiae, have been grouped together based on the clinical syndrome of mastitis,
arthritis, keratitis, pneumonia, and septicemia (MAKePS) caused with infection
(Thiacourt and Bölske, 1996). Some of the basic characteristics that differentiate the
members of the mycoides cluster are listed in Table 2.4. Economically and
pathologically, the 2 most important members of this group of organisms are M.
mycoides ssp. mycoides LC and M. capricolum ssp. capripneumoniae (DaMassa et al.,
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1992; Lefèvre and Thiacourt, 2004; Walker, 2004). Originally identified as F38, M.
capricolum ssp. capripneumoniae was given a definitive name in 1992 and determined to
be the causative agent of contagious caprine pleuropneumonia (CCPP, DaMassa et al.,
1992; Lefèvre and Thiacourt, 2004; Walker, 2004).
Table 2.4: Mycoplasma mycoides and M. capricolum subgroup species affecting goats
and sheep as primary hosts and differential qualities
Quality

M. capricolum subgroup

Ssp.

mycoides LC1

capri

capricolum

capripneumoniae

Host

goats, sheep, cattle

goats

goats, sheep, cattle

goats

Route

respiratory, oral

respiratory

respiratory, oral

Lung
Pattern

interstitial
bronchopneumonia

edema,
bronchopneumonia

inconsistent,
interstitial pneumonia

widened +/-

widened

not thickened

not thickened

mastitis, arthritis,
peritonitis

mastitis

septicemia, fibrinous
arthritis, mastitis

none

Interlobular septa
Extrapulmonary
1

M. mycoides subgroup

respiratory close
contact
interstitial edema,
abscessation
possible

LC = Large Colony
Contagious caprine pleuropneumonia is similar in many ways to CBPP. A high

fever occurs at the onset of clinical disease which is followed by coughing, respiratory
distress, painful respiration, and a reluctance to move. Morbidity can reach 100%, and
mortality may be as high as 70% (Lefèvre and Thiacourt, 2004). In endemic regions
some animals experience a subacute form with similar but less intense signs. The disease
is transmitted by aerosol and requires close contact because the organism does not
survive in the environment (Lefèvre and Thiacourt, 2004). The incubation period is
generally between 6 and 10 days (Lefèvre and Thiacourt, 2004) but the OIE International
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Animal Health code chapter 14.4 sets the incubation period at 45 days (OIE, 2009b). The
disease occurs in northern, eastern, and central Africa, and the Arabian Peninsula and
Turkey in the Middle East (Lefèvre and Thiacourt, 2004).
Mycoplasma capricolum ssp. capripneumoniae causes a fibrinous
pleuropneumonia which usually affects 1 lung but can also be lobar. Serofibrinous
pleuritis causes the accumulation of large quantities of serous or serosanguinous pleural
fluid. Abscessation of the lungs may occur. There is no widening of the interlobular
septa. The lesions are restricted to the thoracic cavity. Diagnosis of CCPP is difficult
because other species of mycoplasmas and pasteurellas cause similar lesions (Thiacourt
and Bölske, 1996; Lefèvre and Thiacourt, 2004). Differentiation can be made based on
the distribution of lesions because M. capricolum ssp. capripneumoniae only causes
pleuropneumonia (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004). The
organism can be cultured with some difficulty from pleural fluid and lung tissue, and
metabolic or immunologic based tests are required for speciation. One of the common
methods of speciation, inhibition of growth by antiserum, has reduced specificity because
M. capricolum ssp. capripneumoniae shares antigens with M. capricolum ssp. capricolum
and Mycoplasma sp. group 7 (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004).
Recently, PCR methods have been developed to detect organisms in tissues but even
these protocols require additional steps to improve speciation such as endonuclease
digestion; identification is based on the number of fragments generated from the PCR
product (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004).
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The serological tests available for herd-level testing for CCPP are a CF test,
passive hemagglutination inhibition (HI), latex agglutination (LAT), and an indirect
ELISA. None of these tests have been rigorously validated with regards to specificity or
sensitivity (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004). Part of the
problem lays with the many shared antigens among the mycoplasma species. For
example, in an outbreak of CCPP reported in 1989, more goats were seropositive for M.
mycoides ssp. capri than for M. capricolum ssp. capripneumoniae, the only organism
isolated from diseased lungs (Thiacourt and Bölske, 1996). As with CBPP, CF is the test
recognized by the OIE. A blocking-ELISA based on a monoclonal antibody (MAb) is
more specific and does not cross-react with Mycoplasma sp. group 7 (Thiacourt et al.,
1994). When the MAb is used for the detection of antigen in pleural fluid, the limit of
detection is 107 cfu/ml, a level that occurs in acutely infected animals (Thiacourt et al.,
1994). When used in a microtiter plate format, the blocking-ELISA facilitates the testing
of large numbers of samples in a timely and economic manner (Thiacourt et al., 1994;
Thiacourt et al., 1996).
Animals respond best to early treatment with tetracyclines, macrolides or
fluoroquinolones but treatment failures with disease recurrence are common; therefore
some experts have recommended measures that include strict control on animal
movement to prevent the introduction of the disease into a region and rapid institution of
a herd-level test and slaughter protocol when the disease occurs in a new area (Thiacourt
et al., 1996). Use of an inactivated vaccine with a saponin adjuvant has been shown to
create antibodies detectable for a year by CF and greater than a year by competitive
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ELISA, and to result in both reduced mortality and morbidity (Thiacourt et al., 1996). It
is not known if antibody levels directly correspond to the level of protection provided for
this disease. A modified-live vaccine is being assessed and if proven effective would
reduce the cost of immunization (Thiacourt et al., 1996).
Mycoplasma mycoides ssp. mycoides LC and M. mycoides ssp. capri are 99%
identical genetically and while there are serologic differences, they will very likely be
combined into the same subspecies (Nicholas et al., 2008). In contrast to M. capricolum
ssp. capripneumoniae, M. mycoides ssp. capri causes septicemia, polyarthritis,
pericarditis, peritonitis, lymphadenitis, mastitis and conjunctivitis in addition to fever and
interstitial fibrinous pneumonia with widened and pale intralobular septa (DaMassa et al.,
1992; Nicholas et al., 2008). The distribution of disease is worldwide but there is
considerable geographic strain variation with the strains from Africa being less likely to
cause mastitis and arthritis (DaMassa et al., 1992). Mycoplasma mycoides ssp. capri is
the most frequently reported caprine mycoplasma in the United States (Nicholas et al.,
2008). Mycoplasma mycoides ssp. capri can be transmitted orally as well as by
respiratory secretions in contrast to M. capricolum ssp. capripneumoniae which is only
transmitted by respiratory secretions (DaMassa et al., 1992). The growth characteristics
and colony morphology make it easier to diagnose M. mycoides ssp. capri but additional
metabolic and immunogenic tests are also used (DaMassa et al., 1992; Nicholas et al.,
2008). Serologic testing using CF requires an array of antigens due to the similarities
between the organisms of the mycoides cluster (DaMassa et al., 1992; Thiaucourt and
Bölske, 1997). In Europe it is important to distinguish M. mycoides ssp. capri from M.
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capricolum ssp. capripneumoniae as the occurrence of the latter would be the result of a
transborder disease incursion (Nicholas et al., 2008).
Mycoplasma hyopneumoniae
The cause of enzootic pneumonia of swine was determined in 1965 (Kobisch and
Friis, 1996; Wallgren, 2004). This disease is insidious and chronic and as a result the
impact is primarily economic (Wallgren, 2004). Like many of the mycoplasmas that
cause pneumonia, infection begins with inhalation of the organism and subsequent
adhesion to the respiratory epithelium at the apex of the cilia (Kobisch and Friis, 1996;
Wallgren, 2004). When it is the only infectious agent, M. hyopneumoniae causes high
morbidity and low mortality with a dry cough which increases in intensity with exercise
(Wallgren, 2004). A decrease in appetite leads to slowed weight gain which is important
because the disease is most prevalent in growing pigs (Kobisch and Friis, 1996;
Wallgren, 2004). In uncomplicated cases the infection resolves in 10 to 12 weeks,
however, secondary infections are common (Wallgren, 2004).

Co-infection by M.

hyopneumoniae and Pasteurella multocida is more severe than infection by M.
hyopneumoniae alone (Ciprián et al., 1988; Kobisch and Friis, 1996). The lesions occur
most commonly in the ventral regions of the accessory and middle lung lobes and consist
of alveolar interstitial thickening due to marked infiltration by inflammatory cells, giant
cell proliferation, and perivascular lymphoid hyperplasia (Wallgren, 2004).
Diagnosis of M. hyopneumoniae with culture is complicated by slow growth
characteristics and the occurrence of M. hyorhinis (nasal secretions) and M. hyosynoviae
(infected tonsils) in the respiratory tract of swine (Kobisch and Friis, 1996; Wallgren,
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2004). Mycoplasma hyorhinis and M. hyosynoviae both cause polyarthritis (Kobisch and
Friis, 1996). Immunofluorescence and PCR are both more efficient methods than culture
for identifying M. hyopneumoniae in tissues (Wallgren, 2004). Serology is efficient at
detecting the presence of disease in herds because the antibody response is detectable for
as long as 20 weeks (Kobisch and Fris, 1996). Indirect ELISA has become the preferred
method of testing (Kobisch and Fris, 1996; Wallgren, 2004). Control methods for M.
hyopneumoniae have consisted of antibiotics (tetracyclines, macrolides, and some
fluoroquinolones) in the face of outbreaks, especially for naïve herds, but long term use
leads to the development of resistance (Kobisch and Friis, 1996; Wallgren, 2004).
Management methods such as age segregated housing, closed herds, suitable stocking
densities, proper ventilation, and vaccination are effective at controlling M.
hyopneumoniae as well as M. hyorhinis and M. hyosynoviae (Kobisch and Friis, 1996;
Wallgren, 2004). Inactivated, whole-cell vaccines (bacterins) are widely available and in
some countries are used in greater than 70% of herds (Maes et al., 2008). A random
sample survey of swine producers in the United States found that as of 2006, one third of
the producers were immunizing against M. hyopneumoniae (USDA, 2008). Vaccination
strategies include immunizing piglets at 1 to 2 weeks of age, piglets at weaning, and sows
and gilts while pregnant. Vaccination increases weight gain and reduces mortality but
protection is often incomplete (Kobisch and Friis, 1996; Maes et al., 2008). Researchers
are continuing to investigate innovative delivery routes, and subunit and DNA derived
vaccines. A plasma membrane derived vaccine has been tested and shown to provide
protection to the piglets of vaccinated sows (Kobisch et al., 1987).
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Mycoplasma gallisepticum
Like M. hyopneumoniae in swine, losses in poultry due to M. gallisepticum are
primarily economic because the disease caused by the organism is generally chronic and
results in reduced production (Walker, 2004; Bradbury, 2005; Gaunson et al., 2006). Of
the mycoplasmas that infect birds, M. gallisepticum has been studied the most and the
genome has been completely sequenced (Bradbury, 2005). The clinical syndrome is
primarily pulmonary with coughing and respiratory distress in chickens and sinusitis in
turkeys but decreases in egg production can occur in both species (Walker, 2004;
Bradbury, 2005). The organism binds to respiratory epithelium with a specialized
adhesion structure and the prokaryotic surface proteins GapA and CrmA (Bradbury,
2005). Other molecules that may play roles both as adhesins and in evading host immune
defenses by antigenic variation include the lipoprotein VlhA (formerly known as pMGA)
and the membrane protein PvpA (Bradbury, 2005). Mycoplasma gallisepticum has the
ability to penetrate non-phagocytic cells, another method for evading the host immune
system (Bradbury, 2005; Kleven, 2008).
The disease is transmitted via respiratory secretions as with other mycoplasmas.
Mycoplasma gallisepticum is also transmitted to the embryo via infected semen or in egg
development (Bradbury, 2005). Like several of the other pathogenic mycoplasmas, M.
gallisepticum has been found to act synergistically with another pathogen, E. coli in this
case, resulting in increased pathology (Bradbury, 2005). Microscopically, there is
mononuclear infiltration of the respiratory epithelium, and hyperplasia of the mucous
glands (Bradbury, 2005). The immune response, especially the actions of T lymphocytes,
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appears to have a role in the development of pathology (Gaunson et al., 2006).
Resolution of clinical disease corresponds to the development of lymphoid follicles with
B cells dominating the population and a proportional decline in T lymphocytes (Gaunson
et al., 2006).
Because of the impact on production, several countries have attempted to
eliminate M. gallisepticum from their flocks and there has been some success. The
programs have utilized active surveillance, strategic use of antibiotics (tetracyclines,
macrolides, quinolones, and tiamulin), and management practices. The development of
serum plate agglutination and ELISA tests allows for the rapid screening of large
numbers of serum samples for antibodies (Kleven, 2008). Hemagglutination inhibition
tests or PCR are used for confirmation of positive screening test results because nonspecific serum agglutination or ELISA reactions due to recent vaccination or exposure to
other mycoplasmas occur regularly (Kleven, 2008). Reactions to vaccination induced
antibodies are greatly reduced with purified antigens and species specific proteins
(Stipkovits and Kempf, 1996). A blocking ELISA test that uses a MAb against 1 of the
more stable M. gallisepticum proteins can be used to test sera or eggs of any host species
(Stipkovits and Kempf, 1996). Dipping eggs in or injecting them with tylosin (a
macrolide) or tetracycline is effective at eliminating vertical transmission (Stepkovits and
Kempf, 1996; Kleven, 2008). While antibiotics can help to minimize losses in the face of
an outbreak, continual use is not advised and may lead to the development of resistance.
Management techniques such as keeping breeder flocks small, maintaining good
biosecurity, and minimizing the introduction of young males appear to be more effective
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at controlling disease. Vaccination is generally only employed when keeping the flock
free of M. gallisepticum by other methods is not possible. Bacterins have been available
for more than 40 years but provide minimal protection from the disease and economic
losses (Kleven, 2008). There are 3 attenuated strains that have been tested for use in
layers and breeding stock with varying levels of residual virulence, immunity, or adverse
vaccination reactions (Whithear, 1996; Kleven, 2008). The MG 6/85 strain vaccine is
available for commercial use in the United States.
Mycoplasma synoviae
Similar to M. hyosynoviae in pigs, M. synoviae primarily causes synovitis and
retarded growth leading to economic losses in chickens and turkeys (Walker, 2004;
Dufour-Gesbert et al., 2006). Respiratory signs in the form of air sacculitis are usually
subclinical (Walker, 2004; Dufour-Gesbert et al., 2006). Infiltration of the joints and
tendon sheaths by heterophils, deposition of fibrin and subsynovial infiltration by
lymphocytes and macrophages causes swollen joints and tendon sheaths (Walker, 2004;
Bradbury, 2005). Mycoplasma synoviae evades host immune response using variable
surface proteins (VSP) encoded by the gene vlhA but by a different mechanism than that
used by M. gallisepticum (Bradbury, 2005). The methods of control and management
used for M. gallisepticum are also used for M. synoviae (Kleven, 2008).
Mycoplasma bovis
Mycoplasma bovis was first described as a cause of mastitis in 1962 (Pfützner and
Sachse, 1996). Initially identified as M. agalactiae ssp. bovis, in 1976 it was elevated to
a species and is now recognized as a major cause of bovine mastitis, pneumonia, and
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arthritis in Europe, and North and South America (Pfützner and Sachse, 1996; Nicholas
and Ayling, 2003). While M. bovis can cause fatal pneumonia especially in calves, the
impact of infection is primarily through the loss in production that occurs with subclinical
and clinical mastitis (Ghadersohi et al., 1999; Nicholas and Ayling, 2003; Wilson et al.,
1997). In the United States, between 1% and 8% of herds have at least 1 cow infected
with Mycoplasma spp. and the most frequently identified organism is M. bovis (González
and Wilson, 2003; Fox et al., 2005). Clinically, mycoplasma mastitis is characterized by
a rapid decrease in milk production, milk that is tan to grey with fibrin flakes or a gritty
quality, an elevated SCC, and mastitis that shifts from quarter to quarter and is poorly
responsive to antibiotics (Jasper et al., 1966; Pfützner and Sachse, 1996; González and
Wilson, 2003). Generally, the affected cows show only mild signs of systemic disease
(Jasper, 1977; Pfützner and Sachse, 1996; González and Wilson, 2003). Another disease
syndrome caused by M. bovis consists of pneumonia, arthritis and sometimes otitis media
primarily in calves and occasionally in mature cattle (Pfützner and Sachse, 1996;
Nicholas and Ayling, 2003). Morbidity due to pneumonia ranges from 20% to 100% and
the severity of disease increases when other respiratory pathogens such as M. hemolytica,
and P. multocida are present (Van Donkersgoed et al., 1993; Pfützner and Sachse, 1996;
Gagea et al., 2006).
Mycoplasma bovis is transmitted by latent carriers as well as clinically affected
animals to susceptible individuals by direct contact (Pfützner and Sachse, 1996; Nicholas
and Ayling, 2003; González and Wilson, 2003; Fox et al., 2005). Contaminated milking
equipment, personnel, and intramammary infusions used for mastitis treatment have also
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been implicated (Pfützner and Sachse, 1996; González and Wilson, 2003; Nicholas and
Ayling, 2003; Fox et al., 2005). Laboratory studies have indicated environmental
persistence under certain conditions but this has not been considered a significant factor
in the transmission of disease (González and Wilson, 2003; Nicholas and Ayling, 2003).
Infection by M. bovis results in pathologic lesions characterized by necrosis and
lymphoreticular hyperplasia. Acute mastitis is characterized by an early influx of
eosinophils followed by degeneration of the alveolar epithelium (Van der Molen and
Grootenhuis, 1979; Jasper et al., 1987). As the infection progresses the interstitial tissue
is infiltrated by lymphocytes, macrophages, plasma cells and fibroblasts, and hypertrophy
of the epithelium (Van der Molen and Grootenhuis, 1979; Jasper et al., 1987). This is in
contrast to most types of bovine mastitis, where neutrophils are the predominant
responding cell type (Paape et al., 2000). In severe cases, the mammary gland undergoes
atrophy and fibrosis (Jasper et al., 1987). Mycoplasma bovis-pneumonia is characterized
by similar pathologic changes of peribronchiolar infiltration by mononuclear cells,
exudative bronchiolitis, lymphoreticular hyperplasia, fibrinonecrotic pneumonia and
fibrinous pleuritis (Howard et al., 1987; Booker et al., 2008). Infection of the joints
causes fibrinous synovitis and synovial infusion (Blood et al., 1983; Adegboye et al.,
1995; Wilson et al., 2007). The molecular methods of adhesion of M. bovis to host
epithelial tissues are not well understood (Pfützner and Sachse, 1996; Thomas et al.,
2003). Mycoplasma bovis interaction with neutrophils causes an inhibition of
chemiluminescence (Thomas et al., 2003); as noted above, neutrophils are not a major
type of immune cell responding to mycoplasma mastitis. Whether the downregulation of
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chemiluminescence is related to the poor neutrophil response against M. bovis mastitis is
unknown. Studies of the interactions between M. bovis and cells that typically respond to
it, such as eosinophils, lymphocytes, or macrophages would be of interest. Passage of M.
bovis on artificial media results in a decrease in adhesion and a change in the expression
of some of the vsp genes, resulting in a change in VSP expression (Thomas et al., 2003).
Diagnosis of disease due to M. bovis can be done at the herd or individual animal
level and is accomplished through several methods. When the occurrence of
mycoplasma mastitis is suspected in a dairy herd, the recommended diagnostic protocol
is to sample the bulk tank milk 5 times every 3 to 4 d (González and Wilson, 2003; Fox et
al., 2005; Wilson et al., 2009). The sensitivity of a single bulk tank milk culture for
mycoplasmas, the ability to detect Mycoplasma spp. in the bulk tank when there is at
least 1 infected cow in the herd, has been reported as 50%. With sensitivity of a single
sample of 50%, the probability of not detecting infected cows with 5 samples collected 3
to 4 d apart = (1/2)5 = 1/32 = 3%, resulting in a sensitivity (ability to detect at least 1
positive milk sample in a mycoplasma-positive herd) of 97% (Wilson et al., 2009).
Mycoplasma bovis can be reliably cultured from milk on modified Hayflick’s medium
with an atmosphere of 8 to 10% CO2 for 7 to 10 d (Pfützner and Sachse, 1996; González
and Wilson, 2003; Fox et al., 2005). Mycoplasma bovis can also be cultured from
samples of tissues and swabs from joints as long as care is taken to prevent drying and
overgrowth by other bacteria and a transport medium favorable to mycoplasmas such as
CVM is used (Pfützner and Sachse, 1996). Additional methods of detecting the organism
are with ELISA and PCR (Pfützner and Sachse, 1996; González and Wilson, 2003; Fox

31
et al., 2005). Polymerase chain reaction is emerging as the diagnostic method of choice
due to the shortened time needed for results and the sensitivity of the method (Pfützner
and Sachse, 1996; Fox et al., 2005). While an antibody response occurs with infection,
serology is not effective at detecting chronic shedders and acutely infected individuals
(Pfützner and Sachse, 1996; Fox et al., 2005).
Treatment of mycoplasma mastitis is unrewarding even with antibiotics that are
generally effective against mycoplasmas (Pfützner and Sachse, 1996; González and
Wilson, 2003; Fox et al., 2005). Control of mycoplasma mastitis is best done through the
detection and removal from the herd of infected animals (Pfützner and Sachse, 1996;
González and Wilson, 2003; Fox et al., 2005). An infected animal may stop shedding
bacteria in the milk but stressors such as calving may cause the disease to undergo
recrudescence and many authors suggest that adult cows should be considered infected
for life (Pfützner and Sachse, 1996; González and Wilson, 2003; Fox et al., 2005).
Vaccination of cows has not been shown to be effective at eliminating disease (Pfützner
and Sachse, 1996; González and Wilson, 2003; Fox et al., 2005).
In addition to causing mastitis in lactating cows, M. bovis is considered to be 1 of
the most important causes of pneumonia in both dairy and feedlot calves (Radaelli et al.,
2008; Maunsell and Donovan, 2009). Mycoplasma bovis can be cultured from
approximately 10% to 30% of healthy calves and 80% to 92% of herds will have at least
1 calf which will culture positive with a nasal swab (Virtala et al., 1996; Wilson et al.,
2007; Maunsell and Donovan, 2009). Seroconversion, which indicates infection,
coincides with an increase in respiratory disease rates, a decrease in the rate of gain, and
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an increase in the number of antibiotic treatments (Radaelli et al., 2008; Maunsell and
Donovan, 2009). In studies of calves dying from pneumonia, M. bovis has been isolated
alone or with other respiratory pathogens in 30% to 50% of the cases (Virtala et al., 1996;
Maunsell and Donovan, 2009).
There appears to be a difference in the epidemiology of M. bovis pneumonia in
dairy calves and beef calves; a higher proportion of dairy calves contract mycoplasma
infections at an earlier age than do beef calves (Gagea et al., 2006; Booker et al., 2008;
Maunsell and Donovan, 2009). Mycoplasma bovis can be cultured from dairy calves as
young as 1 wk of age and clinical disease is generally diagnosed in calves 2 to 6 wk old
(Maunsell and Donovan, 2009). In herds with mycoplasma mastitis, up to 50% of calves
will have positive nasal cultures (Maunsell and Donovan, 2009). In contrast, in beef
calves, only approximately 20% have a positive antibody titer against M. bovis upon
arrival at a feedlot (after weaning at approximately 6 mo of age). The difference in ages
at which mycoplasma pneumonia is seen in dairy as compared to beef calves is probably
due to the calf management practices typically used in the 2 industries. The practice of
feeding pooled colostrum and discard milk to dairy calves has been shown to transmit M.
bovis to calves, with most developing positive nasal cultures within 2 wk and 37%
developing otitis media (Maunsell and Donovan, 2009). In the beef industry, calves
generally stay with the cow until weaning.
Similar to M. bovis mastitis, treatment of mycoplasma calf pneumonia is
generally unrewarding; calves can improve with early treatment with antibiotics such as
tulathromycin, florfenicol, tilmicosin, and tylosin, but long term prognosis is guarded and
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weight gain is reduced (Rosendal and Martin, 1986; Nicholas and Ayling, 2003;
Maunsell and Donovan, 2009). Management and control methods include pasteurization
of milk and colostrum, segregation of new arrivals to feedlots, metaphylactic (timely
mass medication of a group of animals to eliminate or minimize an expected outbreak of
disease) administration of antibiotics, and possibly improving ventilation and minimizing
crowding (Maunsell and Donovan, 2009). Vaccine trials have shown mixed results. In
some trials, vaccinated groups have had a reduction of clinical disease, an increase in
weight gain and a reduced mortality compared to control groups but in other tests,
vaccination has appeared to exacerbate disease (Maunsell and Donovan, 2009). Because
calves are infected at a very early age, developing an effective vaccine is a challenge
(Maunsell and Donovan, 2009).
Mycoplasma dispar
Mycoplasma dispar is isolated more frequently from healthy calves (prevalence as
high as 90%) than M. bovis, and its role as a primary pathogen is somewhat questionable
(Howard, 1983; Marques et al., 2007; Maunsell and Donovan, 2009). The organism was
identified and characterized in 1968 using a modification of Goodwin’s media (Gourlay
and Leach, 1970). In that study of both normal and pneumonic calves, the organism was
not isolated from normal calves but was found in 49 of 72 of the diseased calves (Gourlay
and Leach, 1970). In contrast, a study of 155 calves with respiratory disease and 146
apparently healthy calves found M. dispar in 35% and 9% of the calves, respectively; M.
bovis was found only in diseased animals (prevalence 12%; Marques et al., 2007).
Additional studies have found that many of the apparently healthy calves with positive M.
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dispar cultures actually have subclinical pneumonia upon histopathologic examination of
the lungs (Howard, 1983). Ultimately, it appears that M. dispar contributes to pathologic
processes which lead to respiratory disease in calves but because the pathologic
mechanism is more subtle and because the organism is fastidious in its growth
requirements, that contribution has been underestimated (Howard et al., 1987; Ayling et
al., 2004).
Mycoplasma dispar does not grow on conventional mycoplasma media but grows
well on a medium with glucose, calf serum, lactalbumin lysate, Hartley’s digest broth,
and homogenized calf thymus (Gourlay and Leach, 1970). On solid media, the colonies
appear lacy with a poorly defined center (Gourlay and Leach, 1970). With repeated
passage, the colonies become more numerous and smaller exhibiting characteristics of
other mycoplasmas (Gourlay and Leach, 1970). Mycoplasma dispar also grows well on
Friis’ medium (Table 1.2) and its use has increased the number of isolations in Britain
(Ayling et al., 2004).
In 1 study of calves with pneumonia, the lesions associated with M. dispar were
fibrinonecrotic bronchopneumonia and suppurative bronchopneumonia (Tegtmeier et al.,
1999). In 84% of the cases, more than 1 organism was isolated (Tegtmeier et al., 1999).
In gnotobiotic calves, the lesions have been described as subtle and primarily consisting
of an alveolitis (Howard et al., 1987). Macrophages appear to be the predominant cell
type found at calf lung infection sites with M. dispar (Howard et al., 1987). The disease
course in the gnotobiotic calves was usually subclinical (Howard et al., 1987).
Mycoplasma dispar appears to affect the course of infection by other bacteria, most often
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P. multocida, by causing ciliostasis (Howard et al., 1987; Virtala et al., 1996; Maunsell
and Donovan, 2009). A study of the effect of M. dispar on an organ culture of bovine
trachea found a marked degeneration of the epithelium, loss of movement in the cilia, and
markedly reduced clearance of Serratia marcescens (Almeida and Rosenbusch, 1994).
Attempts to immunize calves against M. dispar have not been successful because the
organism is poorly immunogenic and may even suppress the immune system (Howard et
al., 1987). Management strategies consist of minimizing stress by addressing ventilation,
temperature, and crowding issues and maximizing fitness with adequate nutrition, and
vaccination for other respiratory diseases (Maunsell and Donovan, 2009).
Mycoplasma agalactiae
Mycoplasma agalactiae causes a disease syndrome in goats and sheep that is very
similar to that of M. bovis in cattle. While the common name of the syndrome is
contagious agalactia and mastitis predominates, keratoconjunctivitis, arthritis (especially
in young animals), and occasionally pleurisy also occur (DaMassa et al., 1992; Smith and
Sherman, 1994). Mycoplasma agalactiae has also been associated with granular
vulvovaginitis of goats (DaMassa et al., 1992). Upon infection, there is a decline in milk
production and the udder may become hot, swollen, and tender (Kahn and Line, 2005).
The milk can have a granular consistency and be yellow in color (Smith and Sherman,
1994; Kahn and Line, 2005). The gland can atrophy and the loss of milk production can
be permanent (Kahn and Line, 2005). Chronically infected sheep or goats shed
organisms in milk and become carriers of the disease (Smith and Sherman, 1994;
McAuliffe et al., 2008). In susceptible herds morbidity can be 30% to 60% (Kahn and
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Line, 2005). Also like M. bovis, M. agalactiae can be transferred by milking equipment,
workers, and by feeding infected milk (DaMassa et al., 1992; Smith and Sherman, 1994;
Kahn and Line, 2005). Microbial culture and PCR can be used to detect the organism in
tissues and milk (Kahn and Line, 2005). Serological tests such as CF, Western blot, and
ELISA can be used to identify infected herds but not for the individual animal because
the serologic response is variable and there is cross reaction with other mycoplasma
species (see discussion for CCPP, Smith and Sherman, 1994). Recently developed serum
ELISA tests have improved sensitivity (100%) and specificity (46% to 92% depending on
the test), respectively (Pépin et al., 2003). The test with the highest specificity uses a
recombinant antigen, P48, a mycoplasma surface membrane protein (Pépin et al., 2003).
Management is more effective than antibiotic treatment for control of the disease (Kahn
and Line, 2005). A recently developed inactivated mineral-oil adjuvanted M. agalactiae
vaccine administered in 2 doses has been shown to prevent clinical disease in sheep
challenged intranasally for up to 8 months following the second vaccination
(Buonavoglia et al., 2010).
Mycoplasma spp. in Wildlife
A number of mycoplasmas have been identified in wildlife, and both newly
described organisms and new hosts for already characterized organisms are being
identified on a regular basis (Kirchoff et al., 1997; Helmick et al., 2002; Hammond et al.,
2003; Haulena et al., 2006). The disease syndromes of conjunctivitis,
bronchopneumonia, polyarthritis, and reduced fertility associated with mycoplasma
infection in wildlife are similar to those that have been described for domestic animals
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(Kirchoff et al., 1997; Helmick et al., 2002; Hammond et al., 2003; Haulena et al., 2006).
There are several differences between the investigation of diseases in wildlife and
domestic animals. The identification of outbreaks is generally more difficult because the
populations of interest are more dispersed and less accessible. When death occurs, the
remains are often discovered in a state of moderate to severe degeneration. The result is
that isolation of the responsible agent and satisfying the requirements of Koch’s
postulates is difficult. The epidemiology, pathology, and population effects of M.
gallisepticum, M. ovipneumoniae, and M. agassizii on populations of the house finch,
bighorn sheep, and tortoises, respectively, are examples of the difficulties of wildlife
disease investigation as well as the effects of mycoplasmas on wildlife populations
(Wobeser, 1994; Rudolph et al., 2007).
Respiratory disease in free-ranging desert tortoises (Gopherus agassizii) was first
observed in the 1970’s in the Beaver Dam Slope region of southern Utah (Brown et al.,
1994). At the same time, population declines had been observed in both the desert
tortoise and the gopher tortoise (G. polyphemus). Tortoises are considered by many
ecologists to be a keystone species in the biome because their dens provide support for
many other species (Brown et al., 1999b). Because of their importance, captive breeding
programs and research stations were established for both species. In 1988, an outbreak of
respiratory disease occurred on an isolated research station in southern California (Brown
et al., 1999a). There was an 86% decline in the population and a 94% decline in adult
animals (Brown et al., 1999a). Investigations of free-ranging desert tortoises found a
mycoplasma, later named M. agassizii, on the surface of the nasal mucosa of affected
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tortoises (Brown et al., 1994). Experimental infection of captive tortoises with M.
agassizii resulted in 7 of 8 animals developing clinical disease; the organism was
recovered from 5 of 7 and a rising titer developed in all exposed animals (Brown et al.,
1994). Studies of free-ranging tortoises have also documented rising titers in association
with clinical signs and increasing prevalence levels of M. agassizii (Brown et al., 1999a;
Dickinson et al., 2005). In addition to desert tortoises, M. agassizii has also been isolated
from gopher tortoises and Geochelone spp. (Brown et al., 1999b).
Infection of tortoises with M. agassizii is characterized by a nasal discharge that
varies from serous to mucoid to purulent, increased lacrimation, conjunctivitis, edema of
the eyelids, anorexia, dehydration, and death (Brown et al., 1999b; Dickinson et al.,
2005). Histologically the infection causes hyperplasia of the epithelium of the affected
tissues, loss of cilia in the respiratory epithelium, and accumulation of lymphoid
aggregates (Brown et al., 1994; Brown et al., 1999b). Detection of the organism is most
efficient with serology via ELISA or PCR (Brown et al., 1999a; Dickinson et al., 2005).
Culture is more difficult than usual for a mycoplasma with growth occurring in 4 to 6
weeks on SP4 media (Brown et al., 1999b). Continued epidemiological studies have
determined that the typical course of the disease is chronic with some animals remaining
infected for more than a year (Brown et al., 1994; Brown et al., 1999b). It is highly
probable that stressors such as drought, changes in vegetation, and human activities
impact the occurrence of disease (Brown et al., 1999a; Dickinson et al., 2005).
The impact and occurrence of M. ovipneumoniae in wild sheep is similar to that
of M. agassizii in tortoises. The first documented disease outbreak occurred in a herd of
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captive Dall’s sheep (Ovis dalli), a species that is closely related to bighorn sheep (O.
canadensis) that were maintained by the Toronto zoo (Black et al., 1988). The outbreak
started when 2 ewes were returned to the herd after a stay at an outside facility where
they had been housed next to a pair of domestic sheep (Black et al., 1988). Two months
after they were returned to the herd, 7 of 10 individuals were coughing (Black et al.,
1988). Ten days after the appearance of disease, 40% of the animals had severe
respiratory distress and despite treatment with several antibiotics and flunixin
meglumine, 2 individuals died (Black et al., 1988). One year after the outbreak some of
the animals still had poor body condition and exercise intolerance (Black et al., 1988).
Since then, M. ovipneumoniae has been associated with several disease outbreaks in
species of bighorn sheep throughout the western United States (Rudolph et al., 2007;
Besser et al., 2008).
The pathology caused by the M. ovipneumoniae was well described in the
outbreak at the Toronto zoo and has been consistent in subsequent disease occurrences.
Fibrinopurulent bronchopneumonia and fibrinous pleuritis are common with the most
severe lesions occurring in the right cranial lobe (Black et al., 1988; Rudolph et al., 2007;
Besser et al., 2008). Microscopically, early lesions have a hyperplastic bronchiolar
epithelium (Black et al., 1988; Rudolph et al., 2007; Besser et al., 2008). As the disease
progresses, lymphoid cuffing, congestion, fibrosis, and necrosis occurs (Black et al.,
1988; Rudolph et al., 2007; Besser et al., 2008). Otitis media has also been documented
in bighorn sheep lambs (Besser et al., 2008).
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Identification of M. ovipneumoniae in the tissues of affected animals has been
difficult and initially the outbreaks of pneumonia in wild sheep were attributed to
Pasteurella spp. and Mannheimia hemolytica (Rudolph et al., 2007; Besser et al., 2008).
Use of Friis’ media appears to improve isolation (Black et al., 1988; Rudolph et al., 2007;
Besser et al., 2008). As with other mycoplasmas which are difficult to culture, both PCR
and serologic tests have been described as efficient at detecting the occurrence of M.
ovipneumoniae in populations. However, sensitivity and specificity calculations have not
been reported (Black et al., 1988; Besser et al., 2008).
The appearance of M. gallisepticum in house finches (Carpodarcus mexicanus)
and other passerines in 1994 was both similar and unique in comparison to outbreaks of
mycoplasmal disease in other wildlife species. The characteristics of this disease
syndrome are dependent upon host and agent factors (Dhondt et al., 2005). The house
finch populations of the eastern United States originated from a group of less than 300
birds imported from the western United States in the 1940s and as such have limited
genetic diversity (Fischer et al., 1997; Dhondt et al., 2005). Genetic analysis of M.
gallisepticum isolates from affected birds in 11 states found the isolates to be identical
indicating a single emergence event in late 1993 or early 1994 which has been localized
to the Washington D.C. area (Fischer et al., 1997; Dhondt et al., 2005). This strain
differed from laboratory reference, vaccine, and poultry strains; however newer DNA
sequencing methods have placed the strain in a cluster with strains isolated from poultry
(Dhondt et al., 2005). The infection causes conjunctivitis that varies from mild to severe
and from which some birds can recover (Luttrell et al., 1998; Dhondt et al., 2005). In
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spite of this, Christmas bird counts and feeder counts carried out by thousands of bird
watchers across the US documented population decreases of up to 60% in the susceptible
species (Dhondt et al., 2005).
Infection of susceptible individuals by M. gallisepticum is characterized by mild
to severe ocular swelling, conjunctivitis, nasal and ocular discharge, and decreased body
condition (Fischer et al., 1997; Luttrell et al., 1998). In a natural outbreak in a group of
captive birds, coughing, sneezing, and rales were not observed (Luttrell et al., 1998).
Histologically, lesions are limited to the periocular tissues, nasal turbinates, and the
trachea (Fischer et al., 1997; Luttrell et al., 1998). Consistent with other mycoplasma
disease, lesions are characterized by mild to severe lymphoplasmacytic infiltrates,
epithelial hyperplasia, and in some cases heterophilic infiltrates (Luttrell et al., 1998).
Experimentally, all finch (Fringillidae) species tested appear to be susceptible
(Farmer et al., 2005). Additional susceptible species include the pine siskin (Carduelis
pinus), tufted titmouse (Baeolophus bicolor), the house sparrow (Passer domesticus), and
the budgerigar (Melopsittacus undulates, Farmer et al., 2005). A survey of songbirds in
Auburn, Georgia detected antibodies to M. gallisepticum in 20 species (Farmer et al.,
2005). Polymerase chain reaction detected M. gallisepticum in 6 species: American
goldfinch (Carduelis tristis), tufted titmouse (Baeolophus bicolor), pine grosbeak
(Pinicola enucleator), evening grosbeak (Coccothraustes vespertinus), house finches
(Carpodarcus mexicanus), and the purple finch (Carpodacus purpureus; Farmer et al.,
2005). Factors affecting the epidemiology of the disease are the adaptation of these
species to human land use patterns, seasonal migration of the eastern populations of
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finches, the use of birdfeeders which increases contact between birds and allows sick
birds to live longer, and the partial immunity that results from infection (Fischer et al.,
1997; Dhondt et al., 2005). The persistence of the disease in the eastern United States is
characterized by regional and seasonal epidemics (Hartup et al., 2000; Dhondt, et al.,
2005; Farmer et al., 2005). Occasionally outbreaks occur in the western bird populations
(Dhondt et al., 2005).
Summary of Mycoplasma Disease
This review of diseases caused by mycoplasmas in man and animals has
demonstrated many similarities. While the course of mycoplasma infections can be acute
as with CBPP and CCPP, a chronic course is more typical. Coinfection with other
bacteria, such as E. coli or Pasteurella spp., or with viruses, such as influenza or
circovirus, can increase the severity of the pathology observed. The pathological lesions
often involve lymphoreticular hyperplasia and fibrinous or fibrinonecrotic degeneration
of lungs, mammary glands, joints and other affected tissues. Identification by culture of
the causative mycoplasma is made more difficult by complex and prolonged growth
requirements. Serologic methods of diagnosis are often used but both the sensitivity
and/or specificity of many tests frequently limits the usefulness for individual animal
diagnosis. Molecular methods, such as various types of PCR, show promise as both
practical and accurate diagnostic methods and many diagnostic laboratories are in the
process of validating various protocols. In addition, PCR is being used to detect
previously unrecognized mycoplasmas in domestic animals and wildlife.
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Mycoplasmas and the Immune System
Response
Mycoplasmas have been found to interact with many different host cell types:
macrophages, polymorphonuclear (PMN) cells, monocytes, follicular dendritic cells,
synovial cells, respiratory epithelial cells, and astrocytes. These interactions result in a
number of immune system reactions. The mycoplasma organisms are able to resist
phagocytosis unless opsonized by specific antibodies (Razin et al., 1998). Both host and
organism strain differences influence the immune reaction and the persistence of the
organisms. Even when evading phagocytosis, mycoplasmas can increase the destruction
of other cells and bacteria by non-specifically stimulating the immune system to produce
enzymes, prostaglandins, toxic oxygen moieties and peroxides, nitric oxide,
proinflammatory cytokines, and chemokines (Razin et al., 1998).
An early in vitro study found that bovine anti-serum specific for M. bovis and M.
dispar increased the ability of cultured bovine alveolar macrophages (BAM) and PMN to
reduce the number of mycoplasmas in the culture supernatant but when rabbit anti-serum
to the same organisms was used, growth of the mycoplasmas occurred (Howard et al.,
1976). This indicates that opsonization of the organisms with antibodies allows immune
cells to kill the organisms only when the antibodies are from the same species as the
cells. Researchers soon determined that some mycoplasmas attached to and even
replicated on the surface of phagocytic cells indicating that the process observed in vitro
was not the same as the process in the animal (Howard et al., 1987; Almeida et al., 1992).
The attachment of mycoplasmas to immune cells could allow the organisms to persist and
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was hypothesized to contribute to the pathology of the disease syndromes (Howard et al.,
1987). A reduction in the severity of lesions could be observed when the immune
response was inhibited pharmacologically suggesting that at least part of the part of the
disease syndrome was due to the host immune response (Howard et al., 1987). As
immunohistochemistry for various cell types developed, researchers found that the lungs
of calves infected with M. bovis contained few PMN cells, and large numbers of mature
macrophages (Howard et al., 1987). At 2 weeks post-infection immunostaining
determined that IgG1-containing plasma cells predominated with smaller numbers of
cells containing IgM, IgG2, and IgA. However, by 4 weeks post-infection, more plasma
cells containing IgG2 were present (Howard et al., 1987). A comparison was made with
calves infected with M. dispar; relatively more IgA producing cells were detected
especially in the cells of the submucosa of the trachea relative to calves infected only
with M. bovis (Howard et al., 1987).
Immunosuppression has been documented in patients infected with certain species
of mycoplasmas (Howard et al., 1987; Almeida et al., 1992; Razin et al., 1998).
Mycoplasma pneumoniae causes a decrease in the response to intradermal tuberculin
(Howard et al., 1987; Razin et al., 1998). Mycoplasma dispar reduced the serologic
response of calves to M. bovis when the calves were simultaneously injected with both
organisms (Howard et al., 1987). Mycoplasma dispar also reduced the lymphocyte
transformation response to bovine respiratory syncytial virus when both were injected
into calves (Howard et al., 1987). The lymphocytes of cattle infected with M. mycoides
ssp. mycoides have a reduced ability to respond to mitogens (Howard et al., 1987).
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The inhibitory effect of mycoplasmas on the immune systems of their respective
hosts is accomplished through different mechanisms, a few of which have been
investigated with advanced biochemical and genomic techniques. The responses of BAM
in cell culture to encapsulated and unencapsulated M. dispar were characterized by
measuring the production of tumor necrosis factor (TNF), interleukin 1 (IL-1), and
glucose (Almeida et al., 1992). For all 3 products, exposure to the purified capsule or the
whole encapsulated organism reduced production by BAM (Almeida et al., 1992).
Moreover, the BAM were unresponsive to endotoxin in the presence of purified capsule
(Almeida et al., 1992). Mycoplasma dispar produces a capsule in vivo as well as in
culture (Almeida et al., 1992). Mycoplasma hyorhinis releases a protein which
suppresses an interleukin-2 (IL-2) dependent cytotoxic T lymphocyte response and T cell
memory (Razin et al., 1998). A deficit of IL-2 also occurs with the suppression of the in
vitro lymphocyte proliferation by M. mycoides ssp. mycoides LC (Poonia and Sharma,
1998). Mycoplasmas may be able to adhere to and cause death by apoptosis of host
animal T cells. Calves infected with M. bovis showed suppressed lymphocyte activity
even though the lymphocytes were not killed as determined by trypan blue exclusion
(Thomas et al., 1990; Razin et al., 1998). Subsequent research using propidium iodide
incorporation, translocation of phosphatidyl serine, detection of a decrease in cell size by
flow cytometry, and detection of DNA ladder generation (an indicator of DNA
fragmentation) determined that there was a loss of cells occurring by apoptosis (Vanden
Bush and Rosenbusch, 2002). A product of the vsp gene family, VSP-L, was found to
suppress lymphocyte proliferation (Vanden Bush and Rosenbusch, 2004). An analogous

46
protein, a product of the avgC gene was identified for M. agalactiae (Santona et al.,
2002).
Many mycoplasma species affect the immune system by causing effector cells to
produce cytokines, both stimulatory and inhibitory, and chemoattractants (Razin et al.,
1998; Yang et al., 2002; Vanden Bush and Rosenbusch, 2003; Thanawongnuwech et al.,
2004; Sun et al., 2006). Mycoplasma bovis, M. capricolum, M. gallisepticum, M.
synoviae, M. hyopneumoniae, M. hyorhinis, and M. mycoides ssp. mycoides induce
macrophages to produce TNF-α, a cofactor for B and T lymphocyte proliferation and
differentiation. Many of the mycoplasmas also increase the production of additional
stimulatory cytokines such as IL-1, IL-1β, IL-6, and IFN-α (Razin et al., 1998). In
contrast, production of proinflammatory TNF-α by macrophages is inhibited by M. dispar
(Razin et al., 1998). Mycoplasma bovis stimulation of TNF-α and interleukin-β occurred
at 100 hours post infection and continued until the end of the study (240 hours) of
experimentally infected cows (via mammary gland infusion; Kauf et al., 2007).
Compared to other organisms that cause intra-mammary infections such as Streptococcus
uberis and Escherichia coli, the induction is delayed by as much as 60 h; this may help
M. bovis to become established in the mammary gland, contributing to its greater
likelihood of becoming a cause of chronic mastitis than S. uberis or E. coli (Kauf et al.,
2007; González and Wilson, 2003). Subtle strain variations have been detected in the
pattern of macrophage cytokine production (Jungi et al., 1996).
Mycoplasma pneumoniae, M. arthritidis, M. fermentens, M. hyopneumoniae, M.
pulmonis, and M. bovis infections are also associated with production of the inhibitory
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cytokine, IL-10, usually later in the course of infection (Razin et al., 1998;
Thanawongnuwech et al., 2004; Sun et al., 2006; Kauff et al., 2007). Mice strains
susceptible to M. pneumoniae expressed more IL-10 mRNA than resistant mice when
exposed to antigen (Sun et al., 2006). Furthermore, the expression of IL-10 mRNA
increased with increasing disease severity (Sun et al., 2006). While pulmonary alveolar
macrophages harvested with bronchoalveolar lavage (BAL) demonstrated increased
production of IL-10 mRNA in pigs infected with M. hyopneumoniae, increased amounts
of IL-10 were not detected in the BAL fluid (Thanawongnuwech et al., 2004). The
authors did not discuss this incongruity but it could be due to sequestration of IL-10
within the lung tissues. Cytokine IL-10 levels were increased in the supernatant of cocultured pulmonary alveolar macrophages and tracheal rings but the IL-10 was not
detected in the macrophages which suggests that epithelial cells possess the ability to
produce this cytokine (Thanawongnuwech et al., 2004). Mycoplasma bovis increases IL10 production in experimentally infected mammary glands 90 hours post-infection;
simultaneous milk sampling determined that there were greater than 106 cfu/ml of M.
bovis in milk at that time (Kauf et al., 2007). The increased production of IL-10 could be
an attempt by the immune system to limit the damage or due to direct stimulation by an
as yet unidentified effector molecule from the mycoplasma (Razin et al., 1998; Sun et al.,
2006). The end result, however, could be impaired clearance of pathogenic organisms
due to the suppression of macrophage function (Thanawongnuwech et al., 2004; Sun et
al., 2006).
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Mycoplasmas are capable of stimulating B cells, T cells, natural killer cells, and
macrophages. Some B cells may become antibody-producing plasma cells, but the
antibodies are not necessarily specific for mycoplasma antigens (Razin et al., 1998). The
non-specific antibodies in combination with the upregulating cytokines further amplify
the inflammatory process and as a result downregulating cytokines are then produced by
effector cells while pathogenic organisms are still present (Razin et al., 1998; Vanden
Bush and Rosenbusch, 2003). This process both reflects and likely contributes to the
chronic nature of many mycoplasma infections (Razin et al., 1998; Vanden Bush and
Rosenbusch, 2003).
Autoimmunity
An additional characteristic of mycoplasma infections is the induction of an
autoimmune process. One mechanism for this effect is the occurrence of shared epitopes
(the part of the macromolecule that is recognized by the immune system) between the
mycoplasma and the host (Razin et al., 1998). Mycoplasma penetrans, which occurs as
an AIDs-associated illness, causes immune system activation in humans through a
complex process that includes glycolipid and lipoprotein mediators (Razin et al., 1998).
Mycoplasma penetrans shares an epitope with CD18, an adhesin that stimulates the
immune system by mediating the interactions between various macrophages and
lymphocytes (Razin et al., 1998). Similar shared epitopes have been found for M.
mycoides ssp. mycoides, M. gallisepticum, M. hyorhinis, M. genitalium, M. pneumoniae,
and M. arthritidis (DeVay and Adler, 1976; Davis et al., 1981; Razin et al., 1998).
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Immune Evasion by Mycoplasmas
In addition to influencing the character of the immune reaction by stimulating the
production of various cytokines and enhancing the maturation of lymphocyte cell lines,
several mycoplasmas possess an ability to rapidly change surface epitopes. The
mechanisms of this process have been studied for several species of mycoplasmas and
have been found to consist of several types of genetic recombination events (Razin et al.,
1998; Beier et al., 1998; Lysnyansky et al., 2001; Nussbaum et al., 2002; Flitman-Tene et
al., 2003). As different strains of M. bovis were subjected to antigenic analysis,
researchers became aware that there was incomplete understanding of the mechanisms by
which strain variation was generated (Rosengarten et al., 1994).
In an early study using MAb, researchers determined that a single epitope
occurred in several different sized integral membrane proteins in several strains of M.
bovis. It was determined by use of an immunoblot method that this variation occurred in
colonies of M. bovis on a culture plate, thus indicating the rate of change was higher than
could be accounted for by random mutation. By examining several different strains
isolated from clinical cases of mastitis, pneumonia, and arthritis and 2 healthy calves it
was determined that the variability of epitope expression could not be correlated with
pathogenicity or the site of isolation. When a chronically infected calf was serially
sampled, similar changes in the membrane proteins were detected indicating that the
same process occurs in vivo (Rosengarten et al., 1994).
Research has progressed with the development of gene and protein sequencing
methods. The genes that code for the VSP have been identified for M. bovis (vsp), M.
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hyorhinis (vlp), M. pulmonis (vsa), and M. agalactiae (avg; Razin et al., 1998; Beier et
al., 1998; Lysnyansky et al., 2001; Nussbaum et al., 2002; Flitman-Tene et al., 2003).
The mechanisms used by each species to attain the maximum amount of variation from a
limited genome are similar and in the case of M. agalactiae and M. bovis, homologous
gene segments are present (Flitman-Tene et al., 2003). Many other bacteria have similar
methods of generating phenotype variability from a single genotype but mycoplasmas are
unique in the amount of variability generated (Razin et al., 1998).
The common characteristics of these gene families are an N-terminal region that
contains a prokaryotic lipoprotein signaling sequence, an exposed C-terminal region of
repetitive units, and an initiation codon that is subjected to site-specific insertion and
deletion (Razin et al., 1998; Beier et al., 1998; Flitman-Tene et al., 2003). The result is a
combination of phase and size variation of the resulting gene product (Razin et al., 1998;
Beier et al., 1998; Flitman-Tene et al., 2003). Phase variation occurs in M. bovis, M.
pulmonis, and M. agalactiae by means of site-specific intergenic recombination and
inversion events (Razin et al., 1998; Lysnyansky et al., 2001; Flitman-Tene et al., 2003).
This mechanism is facilitated by a DNA recombinase in the λ-integrase family (FlitmanTene et al., 2003). Size variation of membrane proteins occurs in M. bovis, M. hyorhinis,
M. hominis, and M. pneumoniae and occurs by the insertion or deletion of repetitive
sequence (Razin et al., 1998; Beier et al., 1998). In M. bovis and M. hyorhinis it is
independent of phase variation (Razin et al., 1998). Finally, there is a rapid ON/OFF
switching of the multiple copies of the membrane protein genes by either insertion of an
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initiator or promoter codon (Razin et al., 1998; Lysnyansky et al., 2001; Flitman-Tene et
al., 2003).
Mycoplasmas elicit a mixture of immunostimulatory, immunosuppressive, and
autoimmune reactions, as well as use surface modification to attempt to evade detection
by the host’s immune system in an effort to continue to reproduce while the host’s
immune system strives to eliminate the undesirable organisms. For many mycoplasmas,
such as M. hyorhinis, M. bovirhinis, and M. salivarium and the host species to which they
are adapted, the balance of elimination and reproduction is relatively even and the lesions
that are produced, minimal (Jungi et al., 1996; Razin et al., 1998; Mahon et al., 2007).
Variations in both host and pathogen characteristics can shift the balance and cause
severe disease to occur. While M. bovis can be isolated from 30% to 50% of calves
dying from pneumonia and cultured from the nasal cavity of 20% of apparently healthy
calves, and 90% of mixed age herds have at least 1 calf that will culture positive, only 8%
of dairy herds will have any mycoplasma, usually M. bovis, in adult cows (González and
Wilson, 2003; Maunsell and Donovan, 2009). Variations in cytokine production by
individuals may explain differences in disease susceptibility. In 1 study of
experimentally induced intramammary infection, 3 out of 4 cows had equal amounts of
IFN-γ and IL-4 producing cells and 1 cow had a significantly greater percentage of IL-4
producing cells. Because IFN-γ is generally classified as stimulating the immune system
and IL-4 causes a downregulation in many immune functions, this difference could
dramatically alter the course of disease. Similar differences have been detected between
M. pulmonis resistant and susceptible strains of mice (Sun et al., 2006). Variations in
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antigenicity, cytokine induction, and immune modulation have been documented in field
isolates and laboratory cultured mycoplasmas but it has been difficult to connect these
variations to changes in pathogenicity and disease syndromes (Beier et al., 1998; Thomas
et al., 2003; Maunsell and Donovan, 2009). It is well recognized that mycoplasmas
become less pathogenic when cultivated in the laboratory and this has been used to
produce vaccines for M. gallisepticum (Whithear, 1996; Kleven, 2008). Another
imbalance between host immunity and the invading pathogenic mycoplasma occurs when
a naïve host species becomes infected as occurs with bighorn sheep and M.
ovipneumoniae, and with house finches and M. gallisepticum. In both of these species,
the introduction of disease was accompanied by notable population declines (Dhondt et
al., 2005; Besser et al., 2008). For many of the mycoplasmas of veterinary importance,
the impact of the disease lies not with the severity of disease but with the rate of
morbidity and the impact on production.
Summary of literature review
In summary, mycoplasmas cause disease in a wide range of animal and bird
species as well as in humans. Infection with these organisms can result in death but more
often results in chronic disease, and in the case of livestock, reduced production.
Mycoplasmas are often difficult to identify as the agents of the disease process because of
their characteristics of growth in culture and the need for specialized media. In addition,
development of antibodies by the host in response to infection is variable making
serologic testing unreliable for detection of infection in individual animals. Areas in need
of additional research in regards to mycoplasma infections are defining virulence factors,
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improving detection of organisms which have prolonged growth curves or fastidious
growth requirements, developing methods which facilitate speciation of closely related
organisms, and incorporating an understanding of microbial ecology into modes of
transmission and environmental persistence.
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CHAPTER 3
SURVIVAL AND REPLICATION OF MYCOPLASMA SPECIES IN RECYCLED
BEDDING SAND AND ASSOCIATION WITH MASTITIS ON DAIRY FARMS IN
UTAH∗
Introduction
Infection with Mycoplasma spp., typically M. bovis, is an important disease
complex of dairy cattle. Mycoplasma spp. can cause mastitis, arthritis, metritis,
pneumonia, septicemia, and death of cattle (Pfützner and Sachse, 1996; Wilson et al.,
2007; Wilson et al., 2009). Standard microbial cultures of milk samples do not isolate
Mycoplasma spp.; special methods are necessary. Therefore, the presenting history
associated with mycoplasma mastitis often includes a frustrating inability to determine
the causative agent after clinical signs appear because of repeated negative results on
standard microbial cultures of milk samples (González et al., 1992; Wilson et al., 2007).
Culled or dead cows, lameness, respiratory disease in calves or adult cattle, and clinical
mastitis which does not respond well to treatment can cause considerable financial loss
(Pfützner and Sachse, 1996). Per case, mycoplasmal infections cause some of the largest
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milk production losses among all mastitis pathogens (Wilson et al., 1997). Mycoplasma
infections are contagious diseases, and are primarily transmitted by milk from infected
cows which contaminates milking equipment and by direct contact with respiratory
secretions (Jasper, 1977; González et al., 1993; Ghazaei, 2006).
During the follow up phase of a statewide prevalence study of mycoplasma
mastitis in Utah, we discovered an outbreak of clinical mycoplasma mastitis on a 4,500
cow dairy farm. This disease outbreak was associated with the isolation of Mycoplasma
spp. from stored recycled bedding sand and from freestall bedding. An earlier reported
outbreak of mycoplasma mastitis in a Florida dairy herd was associated with a
mycoplasma-positive sandlot that was used for calving and to house mastitic cows (Bray
et al., 1997). Additionally, seasonal variation of mycoplasma mastitis has been reported
(González et al., 1992; Bray et al., 1997; González and Wilson, 2003) which could
partially be attributed to seasonal cow stress, but environmental sources may play a role
(Bray et al., 1997). Thus, the existence of environmental sources for Mycoplasma spp.,
including M. bovis, and their role in transmission and clinical disease needs further
investigation.
The objectives of this study were to evaluate the concentration of Mycoplasma
spp. in recycled bedding sand, investigate factors associated with the survival of the
Mycoplasma spp. in recycled bedding sand and determine whether recycled bedding sand
can serve as an environmental source of mycoplasmal infections of dairy cows. The null
hypothesis was that Mycoplasma spp. would not persist in the recycled bedding sand
without constant exposure to infected cows. The first alternative hypothesis was that
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Mycoplasma spp. would persist for a period of time without exposure to infected cows
but then numbers detected would eventually decline to zero. The second alternative
hypothesis was that Mycoplasma spp. numbers would fluctuate over time suggesting
changes in response to changing conditions. We also evaluated 2 methods of elimination
of Mycoplasma spp. from contaminated bedding sand. Confirmation of an environmental
source for Mycoplasma spp. in recycled bedding sand and its association with
mycoplasma-related clinical disease raises possibilities for further investigation of
mycoplasma disease in dairy cattle and could impact management strategies.
Materials and Methods
Study Dairies
Mycoplasma-positive dairy herds were identified in a previously performed
statewide prevalence study in Utah (Wilson et al., 2009). During the follow-up portion of
that study, Dairy 1 experienced an outbreak of clinical mastitis (CM) caused by
Mycoplasma spp. which was associated with the isolation of Mycoplasma spp., of which
2 isolates were found by PCR to be M. bovis, from bedding sand and piles of recycled
bedding sand that was designated to be reused. Dairy 1 had approximately 4,500 milking
cows housed on dry lots and freestalls bedded with recycled sand. The endemic rate of
CM attributable to Mycoplasma spp. was approximately 3 cases/4,500 cows per month.
During the outbreak, aseptic milk samples from all CM cases were cultured from this
herd by the herd health veterinarians (RH and RC). During the CM outbreak, the rate of
mycoplasma mastitis cases increased to approximately 35 cases/4,500 cows per month.
At this dairy, the bedding sand is recycled by scraping it out of the alleys, into a flume
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where the manure is washed free. This is followed by a second washing step on a cement
pad with a low slope. After drying, the sand is swept up and stored for several months in
large, elongated piles (approximately 3.75 m tall and 3.75 m wide by 600 m long) prior to
reuse. Samples of bedding sand from freestalls and the piles of recycled sand were
collected by the herd health veterinarians. Composite bedding sand samples were
collected from 20 freestall housing pens by collecting approximately 3 grams from the
back third of every 10th stall. Samples were identified by date and either the pen number
or pile (letter designation). Dairy 1 began using sand as the only bedding substrate in
2001. In 2004 the dairy began using recycled bedding in all pens and no new sand was
imported with the exception of 1 month at the end of the described CM outbreak.
Dairies 2 through 8 also had Mycoplasma spp. detected in bulk tank milk as part
of the prevalence study (Wilson et al., 2009). Composite bedding samples were collected
(by DW and AJA) from the freestalls of those dairies by collecting approximately 3
grams of material from the back third of 6 to 10 stalls per pen. From hospital pens, 1
sample was collected from each of 6 different areas of the pen. Samples were identified
with the dairy number, date, and pen number. Conventional mycoplasma culture
methods identified Mycoplasma spp. in the freestall bedding sand and recycled sand.
PCR was used to determine whether or not the organisms isolated were M. bovis in 4
samples from Dairy 1. The protocols for each method are described below.
Study Pile of Recycled Bedding Sand
Mycoplasma spp.-positive recycled bedding sand (18,000 kg) was transported
from Dairy 1 to Utah State University (USU) and stored in a pile (approximately 3 m in
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diameter and 2 m tall) outdoors, uncovered on a hard asphalt surface away from animals
or their waste. The outbreak of mycoplasma mastitis at the dairy was resolving when the
sand was removed from the dairy. The sand pile was composite sampled on the surface
(from approximately 0 to 2 cm into the pile) and deep (from approximately 15 to 18 cm
into the pile) layers on a weekly basis for 4 mo, from the beginning of April to the
beginning of August. Each composite sample was collected with a disposable spoon and
consisted of subsamples containing ½ of a spoonful from each of 5 sites within the pile.
After 3, 4, and 5 ½ mo of study, single site samples were taken from very deep
(approximately 50 cm) in the pile. For each sampling, surface and deep, a new plastic
spoon was used. The superficial sand that was removed from the deep sites was replaced
in the sampling site after the sample was removed. Previously sampled sites were easily
identified and a new set of sampling sites were used for each collection. The temperature
of the pile at the surface (2 cm) and deep (18 cm) locations was measured with a standard
digital soil thermometer on each sampling day at 1600 h.
After 4 mo, the pile was composite sampled every 14 to 28 d for the next 2 mo
(August to October). After 6 mo (the beginning of October), the sand was moved by a
construction crew seeking access to a job site; most of the sand was stored in a dump
truck bed and some was taken to a nearby storage site away from animals or their waste,
and then the sand was returned after 24 h. The sand was moved again approximately 3
wk later (October 28), when it was relocated to another outdoor site where it was stored
uncovered, on cement, for use in another study. Weekly sampling resumed and
continued for 7 wk.
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Temperature and Precipitation Records
for Logan Utah
Weather data (daily highs and lows, and daily precipitation in inches) were
obtained from the USU Utah Climate Center for the weather station closest to the sand
pile (lat. 41°44'26", long.-111°48'37", elev. 1,460 m). This weather station is less than 3.2
km from the storage sites of the sand pile.
Sand Composition Testing
Sand nitrogen and carbon content were determined by the Utah State University
Analytical lab (USUAL). A composite sample of approximately 1 kg of sand was
collected from the recycled bedding sand pile 1 mo after the sand arrived at USU.
Additionally, a sample of unused sand from the source sand pit and composite samples of
stored recycled bedding sand from Dairy 1 were tested for total nitrogen, total carbon,
and organic content.
Bedding Culture: from Dairies and from
the Pile of Recycled Bedding Sand
Bedding samples were collected into new ziplock plastic bags. When freestalls
were being sampled, 6 to 10 stalls were sampled from each pen; samples were taken from
the back third of every tenth stall. Samples were held at 4 °C and shipped within 24 h in
padded envelopes to The Dairy Authority Laboratory (TDA, Greeley, Colorado) by
priority mail (2 d delivery). Samples were cultured using 1 g of bedding diluted in
1,000 ml of sterile water to make an initial 1,000 fold dilution. Three additional 1:10
dilutions were made, resulting in 1:104, 1:105, 1:106 dilutions. For all dilutions, 50 µl of
sample was plated and counted to determine colony forming units (cfu/g). Aerobic
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culture was performed using MacConkey, modified Edward’s agar (A70, Hardy
Diagnostics, Santa Maria, CA), and Mannitol Salt agars for 48 h at 37 °C. Plates were
examined at 24 and 48 h and the growth recorded. Mycoplasma culture was performed
on modified Hayflick medium (G102, Hardy Diagnostics) using the same dilutions with
10% CO2 and 80% humidity for 10 d. Plates were examined at 3, 7, and 10 d under 2X
magnification with confirmation at 4X magnification and the colonies morphologically
consistent with Mycoplasma spp. were counted. Mycoplasma plates that were overgrown
with other types of bacteria were defined as contaminated.
Controlled Experiments with Recycled
Bedding Sand
Temperature Trials. Bedding samples were collected from deep in the pile and
incubated at -20 °C, 4 °C, 20 °C, 36 °C, and 60 °C in closed but not sealed petri dishes
for 24, 48, and 72 h. At 36 °C an additional trial was run by adding 250 µl of water at 24
and 48 h of incubation in order keep the sample hydrated. An additional trial consisted of
prolonged incubation for 117 d at 4 °C of 4 recycled bedding sand samples (Samples A,
B, C, and D) from Dairy 1. After incubation for the allotted time, the samples were sent
overnight to TDA on frozen cold packs for mycoplasma culture and cfu/g determination
as described above. Mycoplasma spp. cfu/g were compared to those from the same
samples prior to incubation.
Chemical Disinfection. A large sample was collected from deep in the pile after
2 mo and held at 4 °C for 3 d. Sample fractions (2 g) of the sand were placed in 14 ml
conical tubes, and mixed with 1 of the following: 4 ml of 2% chlorhexidine gluconate
solution (Durvet, Blue Springs, MO); 0.5% chlorhexidine gluconate (1:4 dilution of 2%
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solution); 1:10 dilution of household bleach (Clorox, Oakland CA), 0.5% sodium
hypochlorite; or 1:30 dilution of household bleach (Clorox), 0.17% sodium hypochlorite.
Sterile, deionized sterile water was used as a control. The sand and disinfectant mixtures
were allowed to stand undisturbed for 30 min at room temperature. The chlorhexidine or
sodium hypochlorite was removed by decanting the liquid, adding 8 ml of sterile
deionized water, mixing, settling and decanting of the liquid. The washing procedure
was repeated 3 times. The treated samples (those treated with disinfectant) and the
control samples were shipped on frozen cold packs to TDA for mycoplasma culture and
cfu/g of sample determination.
Conventional PCR Protocol
Sample Preparation. Sample preparation, DNA extraction, PCR and post-PCR
processing were performed at the UVDL. Two 1 g volumes of bedding sand were
washed with phosphate buffered saline (PBS) and the supernatant collected.
Additionally, two 100 mg volumes were placed in 5 ml of PPLO broth and incubated for
24-48 hours at 37 °C in 8% CO2.
DNA extraction. DNA was extracted from 150 µl PPLO broth culture and from
the PBS wash solution with a commercial extraction kit for tissues and fluids (Qiagen,
Valencia, CA). Following the manufacturer’s protocol, briefly, the sample was mixed
with 180 µl of tissue lysis buffer and 20 µl of proteinase K (Qiagen, Valencia, CA) and
incubated at 55 °C for 2 h. After incubation, 200 µl of AL (Qiagen, Valencia, CA) buffer
were added and the mixture was incubated for 10 min at 70 °C. After the addition of 200
µl of ethanol, the mixture was transferred to the DNA binding spin column. The column
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was sequentially washed with 500 µl of each of the wash buffers (Qiagen, Valencia, CA)
and centrifuged at 5.9 X g for 1 min. Finally, the DNA was eluted from the column by
the addition of 100 µl of AE (Qiagen, Valencia, CA) buffer and centrifugation. Elution
was performed twice.
Conventional PCR. Two conventional PCR protocols were used to detect
Mycoplasma spp. or M. bovis DNA in the extracted DNA (L. Li, Alabama State
Veterinary Diagnostic Laboratory, Auburn, Alabama, personal communication). The M.
bovis specific PCR master mix consisted of 35 µl of RNase free water, 5 µl of 10X PCR
reaction buffer (Invitrogen, Carlsbad, CA), 1.5 µl MgCl2 (50 mM), 1.0 µl dNTP (10
mM), 1 µl each of the forward and reverse primers (10 pmol/µl), and 2 U of Platinum
Taq (Invitrogen). The forward M. bovis specific primer (MYCO 5, Eurofins MWG
Operon, Huntsville, AL) sequence was 5’ TGATAGCAATATCATAGCGGC 3’ and the
reverse primer (MYCO 6, Eurofins MWG Operon, Huntsville, AL) sequence was 5’
GTAGCATCATTTCCTATGCTAC 3’. The PCR reaction mix consisted of 45 µl of the
PCR master mix and 5 µl of extracted DNA and produced a 400 to 420 bp amplicon
when M. bovis was detected. Each PCR assay included a positive M. bovis DNA control
(M. bovis, ATCC # 25025) and a DNA-negative control (PCR grade water). The PCR
was performed using a conventional thermocycler (Eppendorf Gradient MasterCycler,
Westbury, NY). Cycling conditions for PCR included an initial denaturing step of 95 °C
for 5 min, followed by 40 cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s,
followed by a final step extension step of 72 °C for 5 min. PCR products were analyzed
with a capillary electrophoresis platform (2100 Bioanalyzer, Agilent, Santa Clara, CA) or
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by standard electrophoresis with a 2% agarose gel run at 100 V for 1 h and 20 min for the
identification of a PCR amplicon of equal size to the M. bovis positive control.
The Mycoplasma spp. PCR protocol was a nested procedure. The flanking
reaction used a forward primer, MYCP 1 (5’ ACACCATGGGAGCTGGTAAT 3’,
Eurofins MWG Operon, Huntsville, AL) and a reverse primer MYCP 2 (5’ CTT
CATCGACTTTCAGACCCAAGGCAT 3’, Eurofins MWG Operon, Huntsville, AL)
with the same PCR master mix as in the M. bovis specific protocol. Each PCR reaction
consisted of 5 µl of sample and 45 µl of master mix. The thermocycling conditions were
as follows: 94 °C for 45 s, 29 cycles of 94 °C for 30 s, 55 °C for 2 min, and 72 °C for 1
min, finishing with 72 °C for 5 min and then a 4 °C hold. The nested reaction used the
forward nested primer, MYCO3, (5’ GTTCTTTGAAACTGAAT 3’, Eurofins MWG
Operon, Huntsville, AL) and the reverse nested primer MYCO 4 (5’ GCATCCACC
AAAAACTCT 3’, Eurofins MWG Operon, Huntsville, AL). The PCR master mix for
the nested protocol was 37.5 µl of RNase free water, 5 µl of 10X PCR reaction buffer
(Invitrogen, Carlsbad, CA), 1.5 µl MgCl2 (50 mM), 0.5 µl dNTP (10 mM), 2 µl forward
and reverse primer (20 pmol/µl) and 2 U of Platinum Taq (Invitrogen). Each nested PCR
reaction consisted of 49 µl of master mix and 1 µl of the flanking reaction product. The
thermocycling conditions for this reaction were 94 °C for 45 s, then 33 cycles of the
following sequence: 94 °C for 30 s, 55 °C for 2 min, and 72 °C; the final step of 72 °C
for 5 min was followed by a 4 °C hold. Positive and negative controls were included as
described above. The PCR products were analyzed in the manner described above for the
M. bovis specific reaction.
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Results
Culture of Bedding from Study Dairies
Results of microbial culture of Mycoplasma spp. in bedding sand samples from
the mycoplasma-positive Dairies 1 through 8 are summarized in Table 3.1. Bedding sand
from freestalls of 3 dairies, 1, 3 and 8, cultured positive for Mycoplasma spp. in 20 of 39
samples, 1 of 3 samples, and 6 of 6 samples, respectively (Table 3.1). Of the 2 samples
of recycled bedding sand and the 2 samples of freestall bedding from Dairy 1 tested with
PCR, the presence of Mycoplasma spp. was verified in 2 of the recycled sand samples
and 1 of the freestall bedding samples. Mycoplasma bovis was verified by PCR in 1 sand
sample from freestall pens and 1 sample of recycled sand. The fourth sample was
identified as positive for Mycoplasma spp. by microbial culture but the PCR results were
inconclusive. Except for the identification of Mycoplasma spp. in the straw bedding of
pen 19 of Dairy 8, all of the positive samples were sand or dirt bedding. Mycoplasma
spp. cfu/g were not determined for Dairy 1. The Mycoplasma spp. cfu/g for all other
dairies ranged from 1.2 X 103 to 5.6 X 105.
Dairy 1 Sand Pile Culture Results and
Association with Temperature and
Rainfall
Mycoplasma spp. Culture Results. Results of microbial culture for Mycoplasma
spp. in samples from the pile of recycled bedding sand collected from Dairy 1 following
an outbreak of clinical mycoplasma mastitis are summarized in Table 3.2. At the outset
of the study, both the surface and deep samples were culture-positive with 7.7 X 105
cfu/g and 2.13 X 106 cfu/g of sand, respectively (Table 3.2). The concentration of
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Table 3.1: Detection of Mycoplasma spp. in bedding sand from 8 Utah dairies with
mycoplasma-positive bulk tanks
Date
12/2007
3/2008
6/19/2008
7/3/2008
7/3/2008
7/3/2008
7/3/2008
7/3/2008
7/3/2008
7/3/2008
8/20/2008
8/20/2008
8/20/2008
8/20/2008
10/18/2008
10/18/2008
10/18/2008
10/18/2008
10/18/2008
10/21/2008
10/21/2008
10/21/2008
10/21/2008
10/21/2008
1

Dairy
Dairy 1
Dairy 1 14/20 pens
Dairy 2
Dairy 3 hospital
Dairy 3 pen 2
Dairy 4
Dairy 5
Dairy 6
Dairy 7
Dairy 8 pen 3
Dairy 1 pile A
Dairy 1pile B
Dairy 1 pile C
Dairy 1 pile D
Dairy 3 hospital
Dairy 3 pen 2
Dairy 1 pile E, deep
Dairy 1, 5 piles, 2
superficial3
Dairy 1, 4 piles, 4
deep5
Dairy 8 pen 1
Dairy 8 pen 2
Dairy 8 pen 12
Dairy 8 pen 15
Dairy 8 pen 19

Counts cfu/g
positive1
positive1
neg.
neg.
1,200
neg.
neg.
neg.
neg.
72,000
8,000
8,000
neg.
neg.
neg.
neg.
34,200

Bedding type
sand
sand
sand
sand
sand
straw
dried manure
straw
straw
sand
sand
sand
sand
sand
sand
sand
sand

neg.

sand

neg.

sand

560,000
4,200
30,000
5,600
6,000

sand
sand
sand
sand
straw

cfu/g were not reported
Piles E, F, G, H, I
3
Superficial samples were taken from the surface to a depth of 0 to 1 cm
4
Piles F, G, H, I
5
Deep samples were taken from a depth of 15 to 18 cm
2
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Table 3.2: Mycoplasma spp. (cfu/g) recovered from recycled bedding sand pile and
ambient maximum temperature
Date
3/29/2008
4/6/2008
4/11/2008
4/15/2008
4/29/2008
5/6/2008
5/13/2008
5/20/2008
5/27/2008
6/3/2008
6/11/2008
6/17/2008
6/19/2008
6/30/2008
7/8/2008
7/15/2008
7/22/2008
7/30/2008
8/5/2008
8/20/2008
9/25/2008
10/6/2008
10/10/2008
10/28/2008
10/30/2008
11/6/2008
11/12/2008
11/20/2008
11/28/2008
12/3/2008
12/11/2008
12/17/2008
1
2

Deep
Surface
2,130,000
770,000
990,000
720,000
420,000
neg.
182,000
neg.
2,000
neg.
68,000
neg.
47,600
neg.
3,400
neg.
2,200
neg.
7,800
neg.
60,000
neg.
4,000
neg.
16,800
neg.
2,000
neg.
33,400
neg.
neg.
neg.
600
neg.
neg.
neg.
neg.
neg.
neg.
neg.
neg.
NR
Sand pile moved and replaced
14,200
1,000
Sand moved to calf facility
1,400
neg.
32,000
neg.
600
neg.
200
neg.
neg.
neg.
neg.
neg.
neg.
neg.
3,000
neg.

Tmax. is the maximum ambient temperature in °C.
NR is not recorded.

Tmax °C1
9.4
6.1
6.7
23.3
22.2
23.3
11.1
28.9
12.2
23.3
12.2
30.0
28.9
33.3
30.0
30.6
26.1
33.9
33.3
31.7
25
14.4
20.6
3.9
8.3
11.1
11.1
NR2
NR
NR
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mycoplasmas in surface samples of the recycled sand pile rapidly declined and the
surface became mycoplasma culture-negative after 3 wk (Table 3.2). The samples from
the deep portions of the pile became culture-negative on July 30, 2008 following apparent
cyclic replication of Mycoplasma spp. deep within the pile as evidenced by temporal
fluctuations in cfu/g recovered from the pile that corresponded to changes in temperature
and precipitation. Recovery of Mycoplasma spp. from the sand pile appeared to be
dependent on ambient temperature (Table 3.2). Not included in the table is a sample
taken on July 8th from the very deep (50 cm) layer of the pile. This sample was positive
at 60,000 cfu/g. Subsequent samples from this depth on August 5th and September 25th
(also not included in the table) were negative.
Several factors including ambient and sand pile temperatures, precipitation and
growth of other microorganisms in the pile were investigated to determine their role in
persistence and replication of Mycoplasma spp. within the pile of recycled bedding sand.
Figure 3.1 is a graphical representation of the temperature changes within deep portions
of the sand pile compared to the ambient maximum temperature over the duration of the
study. Initially, the entire pile was visibly and palpably damp; as the spring and summer
progressed, the surface became dry and crusted but the deep interior remained moist even
when the deep samples collected were culture-negative for mycoplasma.
Figure 3.2 demonstrates the association of recovery of Mycoplasma spp. with
temperature within the pile and precipitation. Initially, recovery of Mycoplasma spp. in
the pile declined quickly which was followed by increasing and decreasing isolation of
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Figure 3.1: Temperature (°C) of the bedding sand at the deep level (T deep pile)
compared to the ambient temperature (Tmax) of USU, Logan, Utah.
mycoplasma until the pile temperature stabilized at approximately 30 °C and measurable
precipitation ceased. Mycoplasma spp. cfu/g increased 30-fold (from 2.0 X 103 to 6.0 X
104 cfu/g) and then decreased 3 times between May and July. With the first 2 spikes in
Mycoplasma spp. cfu/g recovered from the pile, the pile temperature was between
15 °C and 20 °C and there were recorded events of moderate precipitation. However, the
last spike in Mycoplasma spp. concentration recovered from the pile during early summer
was not associated with a recorded precipitation event and temperature in the pile was
nearly 30 °C. Following this last spike in replication of Mycoplasma spp., the
concentration of mycoplasma within the pile rapidly declined as the temperature of the
pile reached greater than 30 °C and this high temperature persisted. During the summer
mycoplasmas were not recovered from the pile via culture. Measurable Mycoplasma spp.
growth within the pile reoccurred when pile temperature decreased to 14 °C and
coincided with 2 of the largest precipitation events during the study. Precipitation
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Figure 3.2: Recovery of Mycoplasma spp. within the recycled bedding sand pile and the
cyclic growth of Mycoplasma spp. as it relates to precipitation and temperature. Cfu/g are
reported as actual values x 10-3, Deep temperature = T °C, and precipitation is reported in
inches x 102. Asterisks indicate when the pile was moved (Oct. 7 and Oct. 28).
on Oct. 5 was followed by movement of the pile, the contents were rearranged and mixed
and subsequent samples collected were culture positive for Mycoplasma spp.
(1.4 X 104 cfu/g initially deep within the pile), even though weekly samples during the 6
previous wk were culture negative (Figure 3.2). When the pile was moved a second time
to another outdoor location, there was an additional 20-fold increase in cfu/g (from
1.4 X 103 to 3.2 X 104 cfu/g) of Mycoplasma spp. recovered from the deep layer of the
pile which occurred 8 d following this movement.
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Results demonstrate a positive association with precipitation and pile movement
and increased replication and recovery of Mycoplasma spp. from the pile of recycled
bedding sand, while demonstrating a negative association between recovery of
Mycoplasma spp. and ambient temperatures. After 6 wk of no recovery of Mycoplasma
spp. from the pile, Mycoplasma spp. could be recovered from the pile after the favorable
temperature and moisture conditions returned. Results indicate that there was long-term
survival of Mycoplasma spp. in the most protected strata of the recycled bedding sand,
even during periods when none could be isolated by microbial culture of the more
superficial strata.
Aerobic Culture Results. Figures 3.3 and 3.4 provide a comparison of growth
patterns of Mycoplasma spp. to growth patterns of Gram-negative microorganisms and
Streptococcus spp. within the pile of recycled bedding sand over the duration of the

Figure 3.3: Association of the growth of Mycoplasma spp. and Gram-negative
microorganisms in recycled bedding sand. Cfu/g are reported as actual values x10-3.
Asterisks indicate when the pile was moved (Oct. 7 and Oct. 28).
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study. The Gram-negative microorganisms consisted primarily of Pseudomonas spp.,
and the reported cfu/g ranged from 6.8 X 105 in the deep layer of the bedding pile early in
the year to undetectable in early August. Growth of Gram-negative microorganisms
within the pile preceded (2 events) or coincided (3 events) with rises in Mycoplasma spp.
cfu/g, but occurred at higher magnitude (Figure 3.3). Streptococcus spp. cfu/g ranged
from 2.2 X 105 to undetectable with the highest counts occurring early in the year and in
July. The growth of Streptococcus spp. within the preceded the growth of Mycoplasma
spp. once and coincided with an increase in Mycoplasma spp. twice (Figure 3.4).
Sand Composition
The total nitrogen content was 0.03% and the total carbon content was 1.33% for
the recycled bedding sand pile. The nitrogen and carbon contents are consistent with the
presence of organic matter (Godden et al., 2008) which may play a role in biofilm

Figure 3.4: Growth patterns of Mycoplasma spp. and Streptococcus spp. in recycled
bedding sand. Cfu/g are reported as actual values x10-3. Asterisks indicate when the pile
was moved (Oct. 7 and Oct. 28).
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formation in recycled bedding sand. The unused bedding sand had a total nitrogen
content of 0.01% and a total carbon content of 1.48%. The amount of organic material in
the unused bedding sand was 0.1%. Samples of recycled bedding sand taken from the
stored piles at the dairy had a mean organic content of 2.1%, mean nitrogen content of
0.185% and mean carbon content of 1.23%.
Temperature and Prolonged
Refrigeration Effects on Mycoplasma spp.
Growth and Survival
The controlled temperature experiments were conducted to obtain more data
relative to survival and optimal growth temperatures for Mycoplasma spp. in recycled
bedding sand. Results of these experiments are provided in Tables 3.3 and 3.4.
Mycoplasma spp. survived for 24 h at all controlled temperatures tested except 60 °C
(Table 3.3). For the short term experiments, the highest percent survival rate occurred at
20 °C with 32.5% mycoplasma viable after 48 h and 9.1% mycoplasma viable after 72 h.
At 36 °C, the Mycoplasma spp. remained viable as long as the sand was kept damp
Table 3.3: Percent survival of Mycoplasma spp. at controlled constant temperatures in
recycled bedding sand. Results are expressed as percent survival which was calculated as
the number of organisms at time x divided by the number of organisms at time 0; ND—
not done

1

Time

-20 °C

4 °C

20 °C

36 °C

24 h.
48 h.
72 h.

12.6
6.7
2.5

67.0
6.7
4.8

55.0
32.5
9.1

100
neg.
neg.

36 °C 1
w/H20
ND
7.2
37.5

250 µl of deionized tap water was added at 24, 48, and 72 hours of incubation

60 °C
neg.
neg.
neg.
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by adding 250 µl of water every 24 h. After 72 h the cfu/g of Mycoplasma spp. in sand
increased to 24,000 cfu/g from 4,600 cfu/g at 48 h, indicating possible replication at
36 °C.
A prolonged refrigeration (4 °C) survival experiment was carried out by storing 3
kg samples (n = 4) collected from Dairy 1 for 117 d, moist, in sealed ziplock bags (Table
3.4). Following prolonged incubation at 4 °C, Mycoplasma spp. increased from 8,000
cfu/g to a mean 131,000 cfu/g in 2 of the 4 samples; the other 2 samples remained
negative. Replication of mycoplasma in recycled bedding sand occurred at temperatures
from 4 °C to 36 °C in the laboratory setting. These data are consistent with the effects of
ambient temperature and temperature deep within the sand pile on Mycoplasma spp.
growth patterns observed in the pile of recycled bedding sand that was kept outdoors.
Chemical Disinfection Experiments
The continuing survival of the organisms in the pile of recycled sand suggested
that an environmental source for Mycoplasma spp. could be established; we conducted
experiments to evaluate the efficacy of 2 disinfectants in the reduction or elimination of
mycoplasma in recycled bedding sand. Bleach (sodium hypochlorite) and chlorhexidine
Table 3.4: Recovery of Mycoplasma spp. following prolonged refrigeration of bedding
sand from Dairy 1. Initial cfu/g: collection date 8/20/08; Ending cfu/g: collection date
12/17/08.
Source pile
Dairy 1 pile A
Dairy 1 pile B
Dairy 1 pile C
Dairy 1 pile D

Initial cfu/g
8,000
8,000
neg.
neg.

Ending cfu/g
200,000
62,000
neg.
neg.
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gluconate were chosen on the basis of availability, use in the dairy industry, and for
bleach, low cost. These 2 disinfectants were tested at 2 different concentrations. After
incubation with the disinfectant, the sand was washed 3 times with deionized sterile water
to reduce the disinfectant residue and to reduce inhibition of bacterial growth. Bedding
sand treated with sterile water served as a control for these experiments.
The number of viable (cultivable) Mycoplasma spp. in recycled bedding sand was
reduced in all treatment groups (Table 3.5). Treatment of contaminated sand with 0.5%
chlorhexidine or 0.17% sodium hypochlorite resulted in 97.3% and 93.3% reductions in
colony counts of Mycoplasma spp., respectively. Treatment with higher concentrations of
disinfectants, 2% chlorhexidine and 0.5% sodium hypochlorite, resulted in 100%

Table 3.5: Concentration dependent efficacy of 2 common chemical disinfectants in
reduction of Mycoplasma spp. in contaminated recycled bedding sand. Data represent the
mean of 2 replicates. Calculated percent reduction of Mycoplasma spp. as compared to
the control (sterile water).

Treatment

Chlorhexidine
0.5% Na
gluconate Chlorhexidine 0.17% Na
4
hypochlorite
hypochlorite
gluconate
2%
0.5%

Sterile water
(control)

3

1

mean
survival

9001

neg.2

2,200

neg.

33,000

percent
reduction

97.3%

100%

93.3%

100%

0%

Colony forming units
neg. = Mycoplasma spp. not cultured
3
1:30 bleach
4
1:10 bleach.

2
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reduction of mycoplasma colony counts from contaminated bedding sand – none could be
isolated by culture. Results demonstrate the initial efficacy of 2 common disinfectants in
reducing Mycoplasma spp. in contaminated recycled bedding sand.
Discussion
Classically, recognized modes of transmission of mycoplasma associated disease
in dairy cattle include direct cow to cow transmission by inhalation and respiratory
secretions and through contaminated milking equipment (Jasper, 1977; González and
Wilson, 2003; Nicholas and Ayling, 2003). Others have found mycoplasma pathogens in
cooling ponds and dry lots in association with mycoplasma disease in dairy herds but the
clinical significance of these environmental sources of this infectious agent remains
undetermined (Bray et al., 1997; González and Wilson, 2003). Previous laboratory
studies reported that M. bovis survived up to 236 d in manure and 23 d in drinking water
at 23 °C to 28 °C (González and Wilson, 2003). The finding of multiple Mycoplasma
spp.-positive bedding samples associated with an outbreak of Mycoplasma spp. mastitis
initiated the investigation reported here into the survival of mycoplasma in recycled
bedding sand and factors associated with the persistence of this possible environmental
source of Mycoplasma spp. Previous studies demonstrated that exposure of the teat ends
to microorganisms in bedding can result in the development of mastitis (Kristula et al.,
2005; Godden et al., 2008). The amount of mycoplasma organisms required to induce
mastitis is not well defined but researchers have successfully induced mastitis by direct
teat infusion of 70 cfu of M. bovis (Bennet and Jasper, 1980). In this study the amounts of
Mycoplasma spp. recovered from the recycled bedding sand ranged from 103 to 106cfu/g,
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suggesting that this environmental source may play a role in the epidemiology of
mycoplasma-associated disease.
Moreover, the present results showed that Mycoplasma spp. remained viable in
recycled bedding sand intermittently over a prolonged period of time (8 mo), and that the
concentration of mycoplasma in the sand was associated with temperature, precipitation
(moisture), and possibly, the growth of Gram-negative microorganisms within the pile.
There was renewed isolation of Mycoplasma spp. in the pile of recycled bedding sand
after it had been repeatedly culture-negative for some time. This new isolation of
mycoplasma occurred following the return of favorable growth conditions and movement
of the pile. Utilization of a pooled sampling method should have minimized the
variability in the counts due to location within the pile, so that increases of at least 10fold can be interpreted as true increases in the numbers of organisms per gram. In
addition, the smaller samples that were stored at 4 °C and 36 °C also demonstrated
similar increases. Therefore, it is likely that there was indeed growth of mycoplasma
after the sand pile was moved and conditions were more favorable for growth. A
previous study of aerated and unaerated leachfield soil found that the active microbial
population was 5 times higher in aerated soil (Amador et al., 2006).
Mycoplasma spp. possess a unique combination of traits including: a genome that
has undergone major reduction which includes loss of cell wall production, a resistance to
some antibiotics as a result of the absence of a cell wall, reduced sensitivity to freezing
but increased sensitivity to desiccation and chemical agents, and growth requirements for
exogenous sources of sterols and lipids (Razin et al., 1998; González and Wilson, 2003;
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Walker, 2004). In our recycled sand pile study, we identified the occurrence of factors in
recycled bedding sand over time that supported the establishment of an environmental
source for Mycoplasma spp. Factors included sand pile temperature, precipitation
(moisture), and low levels of organic material. Organic matter will support more
bacterial growth than clean sand and recycled bedding sand contains a low level of
organic material (Godden et al., 2008). The variability of different bedding materials to
support of growth microorganisms has been investigated (Kristula et al., 2005; LeJeune
and Kauffman, 2005; Godden et al., 2008). Depending on the recycling process and
storage conditions, recycled bedding sand will vary in the amount and composition of
organic material that will provide support for bacterial growth (Kristula et al., 2005).
Given that isolation and growth of mycoplasmas in the laboratory requires
complex media that include sterols, lipids and nucleotides, it is unlikely that low levels of
nitrogen and organic compounds would support prolonged survival of mycoplasmas. The
formation of a biofilm community that included mycoplasmas and Gram-negative
organisms could account for the survival and replication of mycoplasmas in what at first
appears to be a growth factor deficient environment. Biofilms are defined as a
heterogeneous but highly organized community of microbial cells collected into
microcolonies embedded in extracellular polymeric substance matrix (Donlan, 2002;
Halverson, 2005). In the cycle of replication and cell death, the other less fastidious
organisms could supply the nutrients required by the mycoplasmas. Sand has been
previously demonstrated as a matrix for biofilm development for Escherichia coli
(Landini and Zehnder, 2002) and Pseudomonas aeruginosa (Holden et al., 2002; Robleto
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et al., 2003). A previous study (McAuliffe et al., 2006) found that many strains of M.
bovis were capable of forming biofilms and in a biofilm M. bovis was more resistant to
desiccation and temperature extremes. Our results support this observation and it may
explain why Mycoplasma spp., including M. bovis can persist in a pile of recycled
bedding sand over the hot, dry summer months.
In this study, the ideal temperature for survival and growth of Mycoplasma spp. in
recycled bedding sand ranged from 15 °C to 20 °C. Mycoplasma spp. replicated in the
sand at 4 °C when stored for 117 d and remained viable at temperature ranges from
4 °C to 27 °C. Our results are consistent with previous investigations of the survivability
of M. pneumoniae (Wright et al., 1968). That study tested the viability of this organism in
an aerosol at controlled temperatures; M. pneumoniae survived best at 15 °C. Another
study found that some species of mycoplasma, including M. bovis, M. bovirhinis, M.
arginini, remained viable from 50 to more than 100 d in liquid media at 4 °C but only
remained viable for 7 to 28 d at outdoor temperatures on paper discs (Nagatomo et al.,
2001).
The present study demonstrated that Mycoplasma spp. occurred in high numbers
in bedding sand from a dairy concurrently experiencing a clinical outbreak of
mycoplasma mastitis and that an environmental source for Mycoplasma spp. can be
established in recycled bedding sand. Therefore, we conducted experiments to evaluate
the efficacy of 2 common disinfectants in the reduction or elimination of Mycoplasma
spp. in recycled bedding sand. Reportedly, the advantage of using sand as a bedding
material is the potential to remove or inactivate most of the microbial contamination
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through washing (Kristula et al., 2005; Godden et al., 2008); however, in our study,
Mycoplasma spp., including some isolates confirmed by PCR as M. bovis, and other
microorganisms could be recovered from washed (recycled) bedding sand. Following
treatment with 2% chlorhexidine and 0.5% sodium hypochlorite, no Mycoplasma spp.
could be isolated from previously positive bedding sand, demonstrating the efficacy of 2
common disinfectants in reducing or eliminating mycoplasma, or at least making it such
that none could be isolated thereby reducing the potential for the transmission of disease.
In summary, Mycoplasma spp. was discovered in high numbers in recycled
bedding sand originating from a dairy experiencing an outbreak of clinical mycoplasma
mastitis, and was also found in bedding from 2 other farms with mycoplasma-positive
cows. Mycoplasma spp. survived in recycled bedding sand for 8 months and replication
was associated with temperature and precipitation. Recycled bedding sand appeared to
be an environmental source of Mycoplasma spp. Results warrant investigation of the
contribution of biofilm formation in the establishment of this environmental source and
the epidemiological role of this source of mycoplasma-associated disease. Chemical
disinfection appeared to be effective, but practicality and cost-effectiveness require
further study. Moisture appears to contribute to the survival and replication of the
organism in bedding sand. This is also an avenue for further investigation because 1
method of reducing the numbers of all bacteria in recycled bedding sand could be to
improve drying by repeatedly turning the piles, at least in arid climates such as in the
western United States.
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CHAPTER 4
SUMMARY AND CONCLUSIONS

The first mycoplasma was identified as a disease agent by Nocard et al. in 1896
when the field of microbiology was in its infancy. Although the organism was too small
to visualize with the optics of the day, they were able to determine that a biologic agent
was the cause of contagious bovine pleuropneumonia, to culture it in a membranous
pouch which resulted in broth solution becoming cloudy in appearance, and to use that
culture solution to cause disease in a susceptible calf (Nocard et al., 1896). The story of
our developing understanding of mycoplasmas illustrates the development of scientific
techniques, methods, and technological advancements: from utilizing chick embryo
cultures to undefined media incorporating animal products to the use of PCR to detect the
presence of mycoplasmas in tissues and fluids (Eaton et al., 1945; Brown et al., 1999;
Bashiruddin et al., 2005); from the identification of the cell types involved in the
pathologic processes to the identification of the cytokines produced in response to the
presence of mycoplasmas (Howard et al., 1987; Razin et al., 1998; Vanden Bush and
Rosenbusch 2003); from the classification of organisms based on morphology and
disease syndrome to reclassification of hemoplasmas based on matching DNA sequences
(Rikihisa et al., 1997). Research of the basic biology of mycoplasmas has revealed that
this group of organisms is both simple and complex.
Many mycoplasmas cause similar disease syndromes and have a tropism for
related tissues. While some of the diseases are acute, such as contagious bovine
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pleuropneumonia and contagious caprine pleuropneumonia, many more present with a
chronic course which heavily impacts production parameters (Wallgren, 2004; Gaunson
et al., 2006; Wilson et al., 2007). Most of the diseases are characterized by
lymphoproliferative infiltrates in the affected tissues which is in contrast to the
polymorphonuclear response seen with many bacterial infections (Jasper et al., 1987;
Brown et al., 1994; Paape et al., 2000). Identification of mycoplasmas as the causative
agent is often difficult, especially in the individual animal because many of the organisms
grow slowly or have complex requirements for growth in culture (Thiacourt and Bölske,
1996; González and Wilson, 2003). Antibody tests are improving in both sensitivity and
specificity but ultimately these tests rely on the animal response to disease which is
highly variable because of the effects on the host immune system (Thiacourt and Bölske,
1996; Wallgren, 2004). Mycoplasmas have mechanisms to evade the host immune
system through rapid variations in immunogenic proteins thus causing the production of
an inconsistent antibody population. By causing the host’s immune system to produce
cytokines that affect the ratio of the T lymphocyte cell populations, they also affect the
level of antibody production, the overall level of activation, and the effectiveness of the
response (Razin et al., 1998). Finally, many of the mycoplasmas share epitopes which
makes separation of species with polyclonal antibodies difficult (DaMassa et al., 1992;
Thiaucourt and Bölske, 1996).
For many of the mycoplasma diseases, the organisms persist within the host,
therefore diagnostic tests which identify the organism itself may be more reliable.
Methods for antigen detection are usually either based on antibodies directed toward the

102
organism such as ELISA, or DNA based such as PCR. Some new tests have been
developed using MAb which have the benefit of being adaptable to field diagnostics
(Thiacourt et al., 1994; Stipkovits and Kempf, 1996). The literature suggests however
that the methods that show real promise for specificity and sensitivity are PCR methods.
Several techniques, such as restriction fragment length polymorphism and denaturing gel
gradient electrophoresis, have been used to analyze the amplicon generated in order to
determine the species, something that is often needed with mycoplasmas as the amplified
genes are often highly conserved but vary in size (Foddai et al., 2005; McAuliffe et al.,
2005). Another method used is to analyze the melt temperature, the temperature at which
the double stranded DNA separates, of amplicons generated. This real-time PCR method
works by detecting the fluorescent marker which is released with the separation of the
DNA. This has been used to detect Mycoplasma spp. contamination of mammalian cell
cultures (Ishikawa et al., 2006).
Another problem associated with mycoplasma infections lies with development of
effective vaccines. An ideal vaccine stimulates an immune response that efficiently
removes organisms from the host without damaging tissues. Because of the
immunomodulatory effect of many mycoplasmas including the production of
upregulating cytokines, the risk of negative vaccine reactions is highly probable with
whole cell bacterins and attenuated vaccines (Whithear, 1996; Kleven, 2008; Maunsell
and Donovan, 2009). Many attenuated mycoplasma vaccines have been developed by
repeated passages in culture but reversion to virulence can occur as the vaccine strain
circulates in the host population (Whithear, 1996; Kleven, 2008). An additional
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challenge to vaccine development is the phase and size variation of cell surface antigens
that occurs in the population of organisms infecting a group of animals; this creates a
moving target for the immune response. As mycoplasma cell surface proteins have been
identified, researchers have begun testing vaccines based on subunits as well as whole
proteins. Some of these have been effective experimentally such as the 1 developed for
M. hyopneumoniae (Kobisch et al., 1987).
For almost all mycoplasmal diseases, the source of infection has generally been
recognized as chronically or latently infected carriers. Documented routes of
transmission include direct contact between animals, indirect contact via contaminated
milking equipment and personnel, and for preweaned animals, the consumption of
contaminated colostrum and milk. Because mycoplasmas lack a cell wall which appears
to increase susceptibility to drying, elevated environmental temperatures, and to some
disinfectants, environmental contamination and exposure have not been considered
significant factors in the disease process. However, a number of researchers have
documented experimental survival of pathogenic mycoplasmas on various substrates at
temperatures ranging from 4 °C to 28 °C (González and Wilson, 2003).
The original research in presented in this thesis describes the survival and
replication of Mycoplasma species, confirmed with PCR as M. bovis in 2 samples, in
recycled bedding sand. The study began with the investigation of an outbreak of
mycoplasma mastitis at a dairy farm in Utah. It was discovered that recycled bedding
sand used in freestalls was positive for M. bovis by microbial culture and conventional
PCR. In order to determine if the presence of M. bovis in the recycled bedding could
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contribute to the persistence of mycoplasma mastitis at the dairy, 18,000 kg was moved
to Utah State University and serially and quantitatively cultured for 8 mo.
While there were times at which mycoplasma organisms could not be recovered
from the pile, samples were intermittently culture positive over a period of 8 months.
There were several factors that appeared to influence the number of mycoplasma
organisms recovered. The project started in the spring with an initial marked decline in
the number of all types of organisms recovered from the deep sampling stratum (15 to 18
cm from the surface). As environmental temperatures climbed above 25 °C and the
weather became drier, the number of mycoplasmas declined to 102 organisms per gram of
sand. Two, one hundred-fold increases were seen during the early part of the summer
and both coincided with moderate precipitation events. As the weather cooled in the fall,
Mycoplasma spp. were again recovered from the bedding pile. An additional factor
appeared to play a role in this increase. Serendipitously and due to factors beyond the
control of the researchers, the recycled bedding sand was removed from the study site,
temporarily stored in a dump truck and then replaced. An additional precipitation event
also occurred. The result was that the number of mycoplasma organisms recovered
increased from undetectable to greater than 104 cfu/g of bedding. This phenomenon
recurred when the pile was purposefully moved by the researchers a month later. These
results suggest that a Mycoplasma spp. which was identified as M. bovis at the outset of
the study was able to replicate in recycled bedding sand, an event previously considered
unlikely based on the culture requirements of the organism.
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Research has determined that Mycoplasma spp. and M. bovis in particular are
capable of forming single species biofilms (a heterogeneous but highly organized
community of microbial cells) in the laboratory (McAuliffe et al., 2006). Sand has been
previously demonstrated as a matrix for biofilm development for Escherichia coli
(Landini and Zehnder, 2002) and Pseudomonas aeruginosa (Holden et al., 2002; Robleto
et al., 2003). Organisms within a biofilm are more resistant to desiccation, changes in
temperature, and some disinfectants (McAuliffe et al., 2006). While it is not clear from
the results, there could be an interaction occurring between the Mycoplasma spp. and
either the Gram-negative organisms, the Gram-positive organisms or both.
The clinical significance of the recovery of M. bovis for 8 months in a pile of
recycled bedding sand is uncertain. Experimentally, mycoplasma mastitis can be caused
with the infusion of as few as 70 cfu into the teat end (Bennet and Jasper, 1980).
Previous studies have shown that exposure of the teat ends to microorganisms in bedding
can result in the development of mastitis (Kristula et al., 2005; Godden et al., 2008). The
amount of Mycoplasma spp. recovered from the recycled bedding sand ranged from 103
to 106 cfu/g, suggesting that this environmental source may play a role in the
epidemiology of mycoplasma-associated disease. Considered together, these points
suggest that contaminated bedding sand could have a role in the perpetuation of a mastitis
outbreak and with seasonal fluctuations in the number of organisms per gram of stored
bedding, could even initiate an outbreak. The results presented in this thesis suggest that
research including investigation of biofilm formation by mycoplasmas and of
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transmissibility of mycoplasma infections from environmental sources to ruminants
including dairy cattle is warranted.
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